Document:

Exhibit

Exhibit 10.04

CLOUDERA, INC.

2017 EMPLOYEE STOCK PURCHASE PLAN

1.Establishment of Plan.  Cloudera, Inc., a Delaware corporation (the “Company”) proposes to grant options to purchase shares of Common Stock to eligible employees of the Company and its Participating Corporations pursuant to this Plan.  The Company intends this Plan to qualify as an “employee stock purchase plan” under Code Section 423 (including any amendments to or replacements of such Section), and this Plan shall be so construed.  Any term not expressly defined in this Plan but defined for purposes of Code Section 423 shall have the same definition herein.  However, with regard to offers of options to purchase shares of Common Stock under the Plan to employees outside the United States working for a Subsidiary or an Affiliate, the Board may offer a subplan or an option that is not intended to meet the Code Section 423 requirements, provided, if necessary under Code Section 423, that the other terms and conditions of the Plan are met.  Subject to Section 14, a total of Three Million (3,000,000) shares of Common Stock is reserved for issuance under this Plan.  In addition, on each February 1 for the first ten (10) calendar years after the first Offering Date, the aggregate number of shares of Common Stock reserved for issuance under the Plan shall be increased automatically by the number of shares equal to one percent (1%) of the total number of outstanding shares of the Company Common Stock on the immediately preceding January 31 (rounded down to the nearest whole share); provided, that the Board or the Committee may in its sole discretion reduce the amount of the increase in any particular year; and, provided further, that the aggregate number of shares issued over the term of this Plan shall not exceed Thirty Million (30,000,000)  shares of Common Stock.  The number of shares reserved for issuance under this Plan and the maximum number of shares that may be issued under this Plan shall be subject to adjustments effected in accordance with Section 14 of this Plan. Capitalized terms not defined elsewhere in the text are defined in Section 27.  
2.    Purpose.  The purpose of this Plan is to provide eligible employees of the Company and Participating Corporations with a means of acquiring an equity interest in the Company through payroll deductions, to enhance such employees’ sense of participation in the affairs of the Company and Participating Corporations, and to provide an incentive for continued employment.
3.    Administration.  
(a)    The Plan will be administered by the Compensation Committee of the Board or by the Board (either referred to herein as the “Committee”).  Subject to the provisions of this Plan and the limitations of Section 423 of the Code or any successor provision in the Code, all questions of interpretation or application of this Plan shall be determined by the Committee and its decisions shall be final and binding upon all Participants.  The Committee will have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to determine eligibility and determine which entities shall be Participating Corporations, and to decide upon any and all claims filed under the Plan.  Every finding, decision and determination made by the Committee will, to the full extent permitted by law, be final and binding upon all parties.  The Committee will have the authority to determine the Fair Market Value of the Common Stock (which determination shall be final, binding and conclusive for all purposes) in accordance with Section 8 below and to 

interpret Section 8 of the Plan in connection with circumstances that impact the Fair Market Value.  Members of the Committee shall receive no compensation for their services in connection with the administration of this Plan, other than standard fees as established from time to time by the Board for services rendered by Board members serving on the Board or its committees.  All expenses incurred in connection with the administration of this Plan shall be paid by the Company.  For purposes of this Plan, the Committee may designate separate offerings under the Plan (the terms of which need not be identical) in which eligible employees of one or more Participating Corporations will participate, even if the dates of the applicable Offering Periods of each such offering are identical.  The Committee may also establish rules to govern transfers of employment among the Company and any Participating Corporation, consistent with the applicable requirements of Code Section 423 and the terms of the Plan.  
(b)    The Committee may adopt such rules, procedures and sub-plans as are necessary or appropriate to permit the participation in the Plan by eligible employees who are citizens or residents of a jurisdiction and/or employed outside the United States, the terms of which sub-plans may take precedence over other provisions of this Plan, with the exception of the provisions in Section 1 above setting forth the number of shares of Common Stock reserved for issuance under the Plan; provided, that unless otherwise superseded by the terms of such sub-plan, the provisions of this Plan shall govern the operation of such sub-plan. Further, the Committee is specifically authorized to adopt rules and procedures regarding the application of the definition of Compensation (as defined in Section 9(a) below) to participants on payrolls outside of the United States, handling of payroll deductions and other contributions, taking of payroll deductions and making of other contributions to the Plan, establishment of bank or trust accounts to hold contributions, payment of interest, establishment of the exchange rate applicable to payroll deductions taken and other contributions made in a currency other than U.S. dollars, obligations to pay payroll tax, determination of beneficiary designation requirements, tax withholding procedures and handling of stock certificates that vary with applicable local requirements. 
4.    Eligibility.  Any employee of the Company or the Participating Corporations is eligible to participate in an Offering Period under this Plan except the following (other than where exclusion of such employees is prohibited by applicable law):
(a)    employees who are not employed by the Company or a Participating Corporation prior to the beginning of such Offering Period or prior to such other time period as specified by the Committee;  
(b)    employees who are customarily employed for twenty (20) or less hours per week; 
(c)    employees who are customarily employed for five (5) months or less in a calendar year; 
(d)    employees who, together with any other person whose stock would be attributed to such employee pursuant to Section 424(d) of the Code, own stock or hold options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or any of its Participating Corporations or who, as a result 

2

of being granted an option under this Plan with respect to such Offering Period, would own stock or hold options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or any of its Participating Corporations; 
(e)    employees who do not meet any other eligibility requirements that the Committee may choose to impose (within the limits permitted by the Code and other applicable laws); and
(f)    individuals who provide services to the Company or any of its Participating Corporations as independent contractors who are reclassified as common law employees for any reason except for federal income and employment tax purposes.
The foregoing notwithstanding, an individual shall not be eligible if his or her participation in the Plan is prohibited by the law of any country that has jurisdiction over him or her, if complying with the laws of the applicable country would cause the Plan to violate Section 423 of the Code, or if he or she is subject to a collective bargaining agreement that does not provide for participation in the Plan.

5.    Offering Dates.  
(a)    While the Plan is in effect, the Committee shall determine the duration and commencement date of each Offering Period, provided that an Offering Period shall in no event be longer than twenty-seven (27) months, except as otherwise provided by an applicable subplan. Offering Periods may be consecutive or overlapping.  Each Offering Period may consist of one or more Purchase Periods during which payroll deductions of Participants are accumulated under this Plan.  While the Plan is in effect, the Committee shall determine the duration and commencement date of each Offering Period and Purchase Period, provided that a Purchase Period shall in no event end later than the close of the Offering Period in which it begins. Purchase Periods shall be consecutive.    
(b)    The initial Offering Period shall commence on the Effective Date, and shall end with the Purchase Date that occurs on December 20th, 2017 or another date selected by the Committee (but in any event not more than twenty-seven (27) months after the Effective Date) (the “Initial Offering Period”).  The Initial Offering Period shall consist of a single Purchase Period unless otherwise determined by the Committee.  Thereafter, a new six-month Offering Period shall commence on each subsequent December 21st and June 21st, with each such Offering Period consisting of a single six-month Purchase Period ending on or prior to June 20th or December 20th, respectively, except as otherwise provided by the Committee.  The Committee shall have the power to change these terms as provided in Section 25 below.  
6.    Participation in this Plan.  
(a)    Any employee who is an eligible employee determined in accordance with Section 4 immediately prior to the Initial Offering Period will be automatically enrolled in the Initial Offering Period at a contribution level equal to fifteen percent (15%) of Compensation.  

3

Notwithstanding the foregoing, an eligible employee may elect once to decrease his or her contribution rate for the Initial Offering Period by delivering, if the Committee presents a subscription agreement to the automatically enrolled employees during such Initial Offering Period, a subscription agreement to the Company and/or an authorized third party administrator (the “Third Party Administrator”) within thirty (30) days after the filing of an effective registration statement pursuant to Form S-8, or such longer time as may be determined by the Committee. 
(b)    A Participant that is automatically enrolled in the Initial Offering Period pursuant to this section is required to file a subscription agreement, or electronic representation thereof, to the Company and/or a Third Party Administrator in order to continue participation in this Plan with respect to the Offering Period immediately following the Initial Offering Period.
(c)    With respect to subsequent Offering Periods, an eligible employee determined in accordance with Section 4 may elect to become a Participant by submitting a subscription agreement, or electronic representation thereof, to the Company and/or the Third Party Administrator, prior to the commencement of the Offering Period to which such agreement relates in accordance with such rules as the Committee may determine.  
(d)    Except as provided pursuant to Sections 6(a) or (b) above with respect to a Participant who is automatically enrolled in the Initial Offering Period, once an employee becomes a Participant in an Offering Period, then such Participant will automatically participate in each subsequent Offering Period commencing immediately following the last day of such prior Offering Period at the same contribution level unless the Participant withdraws or is deemed to withdraw from this Plan or terminates further participation in the Offering Period as set forth in Section 11 below or otherwise notifies the Company of a change in the Participant’s contribution level by filing an additional subscription agreement or electronic representation thereof with the Company and/or the Third Party Administrator, prior to the next Offering Period.  A Participant that is automatically enrolled in a subsequent Offering Period pursuant to this section (i) is not required to file any additional subscription agreement in order to continue participation in this Plan and (ii) will be deemed to have accepted the terms and conditions of the Plan, any sub-plan and subscription agreement in effect at the time each subsequent Offering Period begins, subject to Participant’s right to withdraw from the Plan in accordance with the withdrawal procedures in effect at the time.  
7.    Grant of Option on Enrollment.  Becoming a Participant with respect to an Offering Period will constitute the grant (as of the Offering Date) by the Company to such Participant of an option to purchase on the Purchase Date up to that number of shares of Common Stock determined by a fraction, the numerator of which is the amount of the contribution level for such Participant multiplied by such Participant’s Compensation (as defined in Section 9 below) during such Purchase Period and the denominator of which is the lower of (i) eighty-five percent (85%) of the Fair Market Value of a share of the Common Stock on the Offering Date (but in no event less than the par value of a share of the Company’s  Common Stock), or (ii) eighty-five percent (85%) of the Fair Market Value of a share of the Common Stock on the Purchase Date (but in no event less than the par value of a share of the Common Stock); provided, however, that for the Purchase Period within the Initial Offering Period, the numerator shall be fifteen percent (15%) of the Participant’s Compensation for such Purchase Period, or such lower percentage as determined by the Committee prior to the 

4

Effective Date or pursuant to a Participant’s election to lower the amount as set forth in Section 6(a) above, and provided, further, that the number of shares of Common Stock subject to any option granted pursuant to this Plan shall not exceed the lesser of (x) the maximum number of shares set by the Committee pursuant to Section 10(b) below with respect to the applicable Purchase Date, or (y) the maximum number of shares which may be purchased pursuant to Section 10(a) below with respect to the applicable Purchase Date.  
8.    Purchase Price.  The Purchase Price in any Offering Period shall be eighty-five percent (85%) of the lesser of:
(a)    The Fair Market Value on the Offering Date; or
(b)    The Fair Market Value on the Purchase Date.
9.    Payment of Purchase Price; Payroll Deduction Changes; Share Issuances.  
(a)    Except with respect to the Initial Offering Period, and unless for such Initial Offering Period the Participant has delivered a subscription agreement authorizing payroll deductions within thirty (30) days after the filing of an effective registration statement pursuant to Form S-8, or such longer time as may be determined by the Committee, in which case the payment of the Purchase Price of the shares shall be by check on the Purchase Date, the Purchase Price of the shares is accumulated by regular payroll deductions made during each Offering Period, unless the Committee determines that contributions may be, or are required to be, made in another form (due to local law requirements, in another form with respect to categories of Participants outside the United States).  The deductions are made as a percentage of the Participant’s compensation in one percent (1%) increments not less than one percent (1%), nor greater than fifteen percent (15%) or such lower limit set by the Committee.  “Compensation” shall mean base salary and regular hourly wages (or in foreign jurisdictions, equivalent cash compensation) and bonuses and incentive compensation, not including commissions and shift differentials; however, the Committee may at any time prior to the beginning of an Offering Period determine that for that and future Offering Periods, Compensation shall mean base salary or regular hourly wages, bonuses, incentive compensation, commissions, overtime, shift premiums, plus draws against commissions (or in foreign jurisdictions, equivalent cash compensation).  For purposes of determining a Participant’s Compensation, any election by such Participant to reduce his or her regular cash remuneration under Sections 125 or 401(k) of the Code (or in foreign jurisdictions, equivalent salary deductions) shall be treated as if the Participant did not make such election.  
(b)    Payroll deductions shall commence (i) as soon as practicable following Participant’s delivery of a subscription agreement with respect to the Initial Offering Period and (ii) on the first payday following the beginning of any subsequent Offering Period, and in either case  shall continue to the end of the Offering Period unless sooner altered or terminated as provided in this Plan.  Notwithstanding the foregoing, the terms of any subplan may permit matching shares without the payment of any purchase price.
(c)    Subject to Section 25 below and to the rules of the Committee, a Participant may decrease the rate of payroll deductions during an Offering Period (including any decrease 

5

pursuant to Section 6) by filing with the Company or the Third Party Administrator a new authorization for payroll deductions, with the new rate to become effective as soon as reasonably practicable and continuing for the remainder of the Offering Period unless changed as described below.  A decrease in the rate of payroll deductions may be made once during an Offering Period or more or less frequently under rules determined by the Committee.  An increase in the rate of payroll deductions may not be made during an Offering Period unless otherwise determined by the Committee.  A Participant may increase or decrease the rate of payroll deductions for any subsequent Offering Period by filing with the Company or the Third Party Administrator a new authorization for payroll deductions prior to the beginning of such Offering Period, or such other time period as may be specified by the Committee.
(d)    Subject to Section 25 below and to the rules of the Committee, a Participant may reduce his or her payroll deduction percentage to zero during an Offering Period by filing with the Company a request for cessation of payroll deductions, and after such reduction becomes effective no further payroll deductions will be made for the duration of the Offering Period.  Payroll deductions credited to the Participant’s account prior to the effective date of the request shall be used to purchase shares of Common Stock in accordance with Section (f) below.  A reduction of the payroll deduction percentage to zero shall be treated as such Participant’s withdrawal from such Offering Period, and the Plan, effective as of the day after the next Purchase Date following the filing date of such request with the Company.
(e)    All payroll deductions made for a Participant are credited to his or her account under this Plan and are deposited with the general funds of the Company, and the Company shall not be obligated to segregate such payroll deductions, except to the extent required to be segregated due to local legal restrictions outside the United States.  No interest accrues on the payroll deductions except to the extent required due to local legal requirements outside the United States.  All payroll deductions received or held by the Company may be used by the Company for any corporate purpose, except to the extent necessary to comply with local legal requirements outside the United States.
(f)    On each Purchase Date, so long as this Plan remains in effect and provided that the Participant has not submitted a signed and completed withdrawal form before that date which notifies the Company and/or the Third Party Administrator that the Participant wishes to withdraw from that Offering Period under this Plan and have all payroll deductions accumulated in the account maintained on behalf of the Participant as of that date returned to the Participant, the Company shall apply the funds then in the Participant’s account to the purchase of whole shares of Common Stock reserved under the option granted to such Participant with respect to the Offering Period to the extent that such option is exercisable on the Purchase Date.  The Purchase Price shall be as specified in Section 8 of this Plan.  Any amount remaining in a Participant’s account on a Purchase Date which is less than the amount necessary to purchase a full share of Common Stock shall be carried forward into the next Purchase Period or Offering Period, as the case may be (except to the extent required due to local legal requirements outside the United States), or as otherwise determined by the Committee.  In the event that this Plan has been oversubscribed, all funds not used to purchase shares on the Purchase Date shall be returned to the Participant, without interest (except to the extent required due to local legal requirements outside the United States).  No Common Stock shall be purchased on a Purchase Date on behalf of any employee whose participation in this 

6

Plan has terminated prior to such Purchase Date (except to the extent required due to local legal requirements outside the United States).
(g)    As promptly as practicable after the Purchase Date, the Company shall issue shares for the Participant’s benefit representing the shares purchased upon exercise of his or her option.
(h)    During a Participant’s lifetime, his or her option to purchase shares hereunder is exercisable only by him or her.  The Participant will have no interest or voting right in shares covered by his or her option until such option has been exercised. 
(i)    To the extent required by applicable federal, state, local or foreign law, a Participant shall make arrangements satisfactory to the Company and the Participating Corporation employing the Participant for the satisfaction of any withholding tax obligations that arise in connection with the Plan.  The Company or any Subsidiary or Affiliate, as applicable, may withhold, by any method permissible under applicable law, the amount necessary for the Company or any Subsidiary or Affiliate, as applicable, to meet applicable withholding obligations, including up to the maximum permissible statutory rates and including any withholding required to make available to the Company or any Subsidiary or Affiliate, as applicable, any tax deductions or benefits attributable to the sale or early disposition of shares of Common Stock by a Participant.  The Company shall not be required to issue any shares of Common Stock under the Plan until such obligations are satisfied.
10.    Limitations on Shares to be Purchased.
(a)    No Participant shall be entitled to purchase stock under any Offering Period at a rate which, when aggregated with such Participant’s rights to purchase stock under all other employee stock purchase plans of a Participating Company intended to meet the requirements of Section 423 of the Code, that are also outstanding in the same calendar year(s) (whether under other Offering Periods or other employee stock purchase plans of the Company, its Parent and its Subsidiaries), exceeds $25,000 in Fair Market Value, determined as of the Offering Date (or such other limit as may be imposed by the Code) for each calendar year in which such Offering Period is in effect (hereinafter the “Maximum Share Amount”).  The Company may automatically suspend the payroll deductions of any Participant as necessary to enforce such limit provided that when the Company automatically resumes such payroll deductions, the Company must apply the rate in effect immediately prior to such suspension. 
(b)    The Committee may, in its sole discretion, set a lower maximum number of shares which may be purchased by any Participant during any Offering Period than that determined under Section 10(a) above, which shall then be the Maximum Share Amount for subsequent Offering Periods; provided, however, in no event shall a Participant be permitted to purchase more than Two Thousand Five Hundred (2,500) Shares during any one Purchase Period or such greater or lesser number as the Committee may determine, irrespective of the Maximum Share Amount set forth in (a) and (b) hereof.  If a new Maximum Share Amount is set, then all Participants will be notified of such Maximum Share Amount prior to the commencement of the next Offering Period for which 

7

it is to be effective.  The Maximum Share Amount shall continue to apply with respect to all succeeding Offering Periods unless revised by the Committee as set forth above.  
(c)    If the number of shares to be purchased on a Purchase Date by all Participants exceeds the number of shares then available for issuance under this Plan, then the Company will make a pro rata allocation of the remaining shares in as uniform a manner as shall be reasonably practicable and as the Committee shall determine to be equitable.  In such event, the Company will give written notice of such reduction of the number of shares to be purchased under a Participant’s option to each Participant affected. 
(d)    Any payroll deductions accumulated in a Participant’s account which are not used to purchase stock due to the limitations in this Section 10, and not covered by Section 9(f), shall be returned to the Participant as soon as administratively practicable after the end of the applicable Purchase Period, without interest (except to the extent required due to local legal requirements outside the United States).
11.    Withdrawal.
(a)    Each Participant may withdraw from an Offering Period under this Plan pursuant to a method specified by the Company.  Such withdrawal may be elected at any time prior to the end of an Offering Period, or such other time period as specified by the Committee.  The Committee may set forth a deadline of when a withdrawal must occur to be effective prior to a given Purchase Date in accordance with policies it may approve from time to time.
(b)    Upon withdrawal from this Plan, the accumulated payroll deductions shall be returned to the withdrawn Participant, without interest (except to the extent required due to local legal requirements outside the United States), and his or her interest in this Plan shall terminate.  In the event a Participant voluntarily elects to withdraw from this Plan, he or she may not resume his or her participation in this Plan during the same Offering Period, but he or she may participate in any Offering Period under this Plan which commences on a date subsequent to such withdrawal by filing a new authorization for payroll deductions in the same manner as set forth in Section 6 above for initial participation in this Plan.
(c)    To the extent applicable, if the Fair Market Value on the first day of the current Offering Period in which a participant is enrolled is higher than the Fair Market Value on the first day of any subsequent Offering Period, the Company will automatically enroll such participant in the subsequent Offering Period.  Any funds accumulated in a participant’s account prior to the first day of such subsequent Offering Period will be applied to the purchase of shares on the Purchase Date immediately prior to the first day of such subsequent Offering Period, if any.  
12.    Termination of Employment.  Termination of a Participant’s employment for any reason, including (but not limited to) retirement, death, disability, or the failure of a Participant to remain an eligible employee of the Company or of a Participating Corporation, or Participant’s employer no longer being a Participating Corporation, immediately terminates his or her participation in this Plan (except to the extent required due to local legal requirements outside the United States).  In such event, accumulated payroll deductions credited to the Participant’s account 

8

will be returned to him or her or, in the case of his or her death, to his or her legal representative, without interest (except to the extent required due to local legal requirements outside the United States).  For purposes of this Section 12, an employee will not be deemed to have terminated employment or failed to remain in the continuous employ of the Company or of a Participating Corporation in the case of sick leave, military leave, or any other leave of absence approved by the Company; provided that such leave is for a period of not more than ninety (90) days or reemployment upon the expiration of such leave is guaranteed by contract or statute.  The Company will have sole discretion to determine whether a Participant has terminated employment and the effective date on which the Participant terminated employment, regardless of any notice period or garden leave required under local law.
13.    Return of Payroll Deductions.  In the event a Participant’s interest in this Plan is terminated by withdrawal, termination of employment or otherwise, or in the event this Plan is terminated by the Board, the Company shall deliver to the Participant all accumulated payroll deductions credited to such Participant’s account.  No interest shall accrue on the payroll deductions of a Participant in this Plan (except to the extent required due to local legal requirements outside the United States).
14.    Capital Changes.  If the number of outstanding shares is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then the Committee shall adjust the number and class of Common Stock that may be delivered under the Plan, the Purchase Price and the number of shares of Common Stock covered by each option under the Plan which has not yet been exercised, and the numerical limits of Sections 1 and 10 shall be proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and in compliance with applicable securities laws; provided that fractions of a Share will not be issued.
15.    Nonassignability.  Neither payroll deductions credited to a Participant’s account nor any rights with regard to the exercise of an option or to receive shares under this Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Section 22 below) by the Participant.  Any such attempt at assignment, transfer, pledge or other disposition shall be void and without effect.
16.    Use of Participant Funds and Reports.  The Company may use all payroll deductions received or held by it under the Plan for any corporate purpose, and the Company will not be required to segregate Participant payroll deductions (except to the extent required due to local legal requirements outside the United States).  Until shares are issued, Participants will only have the rights of an unsecured creditor (except to the extent required due to local legal requirements outside the United States).  Each Participant shall receive, or have access to, promptly after the end of each Purchase Period a report of his or her account setting forth the total payroll deductions accumulated, the number of shares purchased, the Purchase Price thereof and the remaining cash balance, if any, carried forward or refunded, as determined by the Committee, to the next Purchase Period or Offering Period, as the case may be.

9

17.    Notice of Disposition.  If Participant is subject to tax in the United States, Participant shall notify the Company in writing if the Participant disposes of any of the shares purchased in any Offering Period pursuant to this Plan if such disposition occurs within two (2) years from the Offering Date or within one (1) year from the Purchase Date on which such shares were purchased (the “Notice Period”).  The Company may, at any time during the Notice Period, place a legend or legends on any certificate representing shares acquired pursuant to this Plan requesting the Company’s transfer agent to notify the Company of any transfer of the shares.  The obligation of the Participant to provide such notice shall continue notwithstanding the placement of any such legend on the certificates.
18.    No Rights to Continued Employment.  Neither this Plan nor the grant of any option hereunder shall confer any right on any employee to remain in the employ of the Company or any Participating Corporation, or restrict the right of the Company or any Participating Corporation to terminate such employee’s employment.
19.    Equal Rights And Privileges.  All eligible employees granted an option under this Plan that is intended to meet the Code Section 423 requirements shall have equal rights and privileges with respect to this Plan or within any separate offering under the Plan so that this Plan qualifies as an “employee stock purchase plan” within the meaning of Section 423 or any successor provision of the Code and the related regulations.  Any provision of this Plan which is inconsistent with Section 423 or any successor provision of the Code shall, without further act or amendment by the Company or the Committee, be reformed to comply with the requirements of Section 423 (unless such provision applies exclusively to options that granted under the Plan that are not intended to comply with the Code Section 423 requirements).  This Section 19 shall take precedence over all other provisions in this Plan.
20.    Notices.  All notices or other communications by a Participant to the Company under or in connection with this Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.
21.    Term; Stockholder Approval.  This Plan will become effective on the Effective Date.  This Plan shall be approved by the stockholders of the Company, in any manner permitted by applicable corporate law, within twelve (12) months before or after the date this Plan is adopted by the Board.  No purchase of shares that are subject to such stockholder approval before becoming available under this Plan shall occur prior to stockholder approval of such shares and the Committee may delay any Purchase Date and postpone the commencement of any Offering Period subsequent to such Purchase Date as deemed necessary or desirable to obtain such approval (provided that if a Purchase Date would occur more than twenty-four (24) months after commencement of the Offering Period to which it relates, then such Purchase Date shall not occur and instead such Offering Period shall terminate without the purchase of such shares and Participants in such Offering Period shall be refunded their contributions without interest, unless the payment of interest is required under local laws).  This Plan shall continue until the earlier to occur of (a) termination of this Plan by the Board (which termination may be effected by the Board at any time pursuant to Section 25 

10

below), (b) issuance of all of the shares of Common Stock reserved for issuance under this Plan, or (c) the tenth anniversary of the first Purchase Date under the Plan.
22.    Designation of Beneficiary.
(a)    If provided in the subscription agreement, a Participant may file a written or electronic designation of a beneficiary who is to receive any shares and cash, if any, from the Participant’s account under this Plan in the event of such Participant’s death subsequent to the end of a Purchase Period but prior to delivery to him of such shares and cash.  In addition, a Participant may file a written or electronic designation of a beneficiary who is to receive any cash from the Participant’s account under this Plan in the event of such Participant’s death prior to a Purchase Date.  Such form shall be valid only if it was filed with the Company and/or the Third Party Administrator at the prescribed location before the Participant’s death.
(b)    Such designation of beneficiary may be changed by the Participant at any time by written notice filed with the Company at the prescribed location before the Participant’s death.  In the event of the death of a Participant and in the absence of a beneficiary validly designated under this Plan who is living at the time of such Participant’s death, the Company shall deliver such cash to the executor or administrator of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares or cash to the spouse or, if no spouse is known to the Company, then to any one or more dependents or relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.
23.    Conditions Upon Issuance of Shares; Limitation on Sale of Shares.  Shares shall not be issued with respect to an option unless the exercise of such option and the issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act, the Exchange Act, the rules and regulations promulgated thereunder, and the requirements of any stock exchange or automated quotation system upon which the shares may then be listed, exchange control restrictions, securities law restrictions or other applicable laws outside the United States, and shall be further subject to the approval of counsel for the Company with respect to such compliance.  Shares may be held in trust or subject to further restrictions as permitted by any subplan.
24.    Applicable Law.  The Plan shall be governed by the substantive laws (excluding the conflict of laws rules) of the State of Delaware.
25.    Amendment or Termination.  The Committee, in its sole discretion, may amend, suspend, or terminate the Plan, or any part thereof, at any time and for any reason. If the Plan is terminated, the Committee, in its discretion, may elect to terminate all outstanding Offering Periods either immediately or upon completion of the purchase of shares of Common Stock on the next Purchase Date (which may be sooner than originally scheduled, if determined by the Committee in its discretion), or may elect to permit Offering Periods to expire in accordance with their terms (and subject to any adjustment pursuant to Section 14). If an Offering Period is terminated prior to its previously-scheduled expiration, all amounts then credited to Participants’ accounts for such Offering Period, which have not been used to purchase shares of Common Stock, shall be returned 

11

to those Participants (without interest thereon, except as otherwise required under local laws) as soon as administratively practicable. Further, the Committee will be entitled to establish rules to change the Purchase Periods and Offering Periods, limit the frequency and/or number of changes in the amount contributed during a Purchase Period or an Offering Period, permit payroll withholding in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the administration of the Plan, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each Participant properly correspond with amounts contributed from the Participant’s Compensation, and establish such other limitations or procedures as the Committee determines in its sole discretion advisable which are consistent with the Plan. Such actions will not require stockholder approval or the consent of any Participants.  However, no amendment shall be made without approval of the stockholders of the Company (obtained in accordance with Section 21 above) within twelve (12) months of the adoption of such amendment (or earlier if required by Section 21) if such amendment would: (a) increase the number of shares that may be issued under this Plan; or (b) change the designation of the employees (or class of employees) eligible for participation in this Plan.  In addition, in the event the Committee determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences, the Committee may, in its discretion and, to the extent necessary or desirable, modify, amend or terminate the Plan to reduce or eliminate such accounting consequences including, but not limited to:  (i) amending the definition of compensation, including with respect to an Offering Period underway at the time; (ii) altering the Purchase Price for any Offering Period including an Offering Period underway at the time of the change in Purchase Price; (iii) shortening any Offering Period by setting a Purchase Date, including an Offering Period underway at the time of the Committee action; (iv) reducing the maximum percentage of compensation a participant may elect to set aside as payroll deductions; and (v) reducing the maximum number of shares of Common Stock a Participant may purchase during any Offering Period.  Such modifications or amendments will not require approval of the stockholders of the Company or the consent of any Participants. 
26.    Corporate Transactions.  In the event of a Corporate Transaction (as defined below), each outstanding right to purchase Common Stock will be assumed or an equivalent option substituted by the successor corporation or a parent or a subsidiary of the successor corporation.  In the event that the successor corporation refuses to assume or substitute for the purchase right, the Offering Period with respect to which such purchase right relates will be shortened by setting a new Purchase Date (the “New Purchase Date”) and will end on the New Purchase Date.  The New Purchase Date shall occur on or prior to the consummation of the Corporate Transaction, and the Plan shall terminate on the consummation of the Corporate Transaction.
27.    Definitions.
(a)    “Affiliate” means any entity, other than a Subsidiary or Parent, (i) that, directly or indirectly, is controlled by, controls or is under common control with, the Company and (ii) in which the Company has a significant equity interest, in either case as determined by the Committee, whether now or hereafter existing.
(b)    “Board” means the Board of Directors of the Company.

12

(c)    “Code” means the United States Internal Revenue Code of 1986, as amended.
(d)     “Common Stock” means the common stock of the Company.
(e)    “Corporate Transaction” means the occurrence of any of the following events: (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; or  (ii) the consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets; or (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
(f)    “Effective Date” means the date on which the Registration Statement covering the initial public offering of the shares of Common Stock is declared effective by the United States Securities and Exchange Commission.
(g)    “Exchange Act” means the United States Securities Exchange Act of 1934, as amended.
(h)    “Fair Market Value” means, as of any date, the value of a share of Common Stock determined as follows:
(i)     if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in The Wall Street Journal or such other source as the Committee deems reliable; or
(ii)     if such Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in The Wall Street Journal or such other source as the Committee deems reliable; or
(iii)    if such Common Stock is publicly traded but is neither quoted on the Nasdaq Market nor listed or admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in The Wall Street Journal or such other source as the Committee deems reliable; 
(iv)    with respect to the Initial Offering Period, Fair Market Value on the Offering Date shall be the price at which shares of Common Stock are offered to the public by the Company’s underwriters pursuant to the Registration Statement covering the initial public offering of shares of Common Stock; and

13

(v)    if none of the foregoing is applicable, by the Committee in good faith.
(i)    “Offering Date” means the first business day of each Offering Period.  However, for the Initial Offering Period the Offering Date shall be the Effective Date.
(j)    “Offering Period” means a period with respect to which the right to purchase Common Stock may be granted under the Plan, as determined by the Committee pursuant to Section 5(a).
(k)    “Parent” shall have the same meaning as “parent corporation” in Sections 424(e) and 424(f) of the Code.
(l)    “Participant” means an eligible employee who meets the eligibility requirements set forth in Section 4 and who is either automatically enrolled in the Initial Offering Period or who elects to participate in this Plan pursuant to Section 6. 
(m)    “Participating Corporation” shall mean any Parent, Subsidiary or Affiliate that the Board designates from time to time as a corporation that shall participate in this Plan.
(n)    “Plan” means this Cloudera, Inc. 2017 Employee Stock Purchase Plan.
(o)    “Purchase Date” means the last U.S. business day of each Purchase Period.
(p)    “Purchase Period” means a period during which contributions may be made toward the purchase of Common Stock under the Plan, as determined by the Committee pursuant to Section 5(b).
(q)    “Purchase Price” means the price at which Participants may purchase a share of Common Stock under the Plan, as determined pursuant to Section 8.
(r)    “Securities Act” means the United States Securities Act of 1933, as amended.
(s)    “Subsidiary” shall have the same meaning as “subsidiary corporation” in Sections 424(e) and 424(f) of the Code.

14

Participating Corporations

Cloudera (UK) Limited

Cloudera Hungary Kft

	
		
	CLOUDERA, INC. (THE “COMPANY”)
2017 EMPLOYEE STOCK PURCHASE PLAN
	ENROLLMENT /CHANGE FORM
FOR INITIAL OFFERING PERIOD
COMMENCING ON IPO EFFECTIVE DATE

	
			
	SECTION 1:
ACTIONS
	CHECK DESIRED ACTION:                                  AND COMPLETE SECTIONS:
 o  Confirm / Change Contribution Percentage               2 + 4 + 16
 o  Opt out                                                                        2 + 5 + 16

	SECTION 2:
PERSONAL DATA
	Name:                                                                                          
Home Address:                                                                            
                                                                                                     
Work Email:                                                                                
	Employee ID:
                              

	SECTION 3:
CONFIRMING ENROLLMENT
	I understand that I have been automatically enrolled in the ESPP, and I hereby elect to continue to participate in the ESPP.  I understand that my enrollment was effective at the beginning of the initial Offering Period.  As a result of that enrollment, I am electing to purchase shares of the Common Stock of the Company pursuant to the ESPP and any sub-plan thereto for my country of residence (if any) (the “Sub-Plan”) (together, the “ESPP”), this Enrollment/Change Form and any appendix to this Enrollment/Change Form for my country (if any) (the “Appendix”).  I understand that the shares purchased on my behalf will be issued in street name and deposited directly into my brokerage account at the Company’s captive broker.  I hereby agree to take all steps, and sign all forms, required to establish an account with the Company’s captive broker for this purpose.
My participation will continue as long as I remain eligible, unless I withdraw from the ESPP by filing an Enrollment/Change Form with the Company or the Third Party Administrator (as defined in the ESPP).  I understand that, if I am subject to tax in the U.S., I must notify the Company of any disposition of shares purchased under the ESPP.

	SECTION 4:
ELECT/CHANGE CONTRIBUTION PERCENTAGE
	I understand that I am currently automatically enrolled in the ESPP at a contribution level equal to 15% of my Compensation (as defined in the ESPP).  My contributions will be applied to the purchase of shares of Common Stock pursuant to the ESPP.  
I hereby authorize the Company or the Parent, Subsidiary or Affiliate employing me (the “Employer”) to either (i) continue the automatic enrollment at the 15% contribution level or (ii) continue the automatic enrollment, but decrease the contribution level, in either case by withholding from each of my paychecks such amount as is necessary to equal at the end of the applicable Offering Period the percentage of my Compensation (as defined in the ESPP) paid to me during such Offering Period as indicated below, so long as I continue to participate in the ESPP.  The percentage must be a whole number (from 1% up to a maximum of 15%).
 o continue my contribution at 15% 
 o decrease my contribution percentage to _____% the reduced percentage must be a whole number from 1%, up to a maximum of 14%).
Note:   For the initial Offering Period, your contribution percentage will be adjusted to take into account the date on which you return this form.  Accordingly, the percentage may be increased to achieve the designated contribution percentage for the full Offering Period.  Notwithstanding the foregoing, this form must be returned within 30 business days following the Effective Date, and if it is not received by that time, you will be required to provide a check for the purchase of the shares for the first Offering Period.
Note:   You may not increase your contributions at any time within an on-going Offering Period.  An increase in your contribution percentage can only take effect with the next Offering Period.  You may decrease your Contribution percentage to a percentage other than 0% only once within an on-going Offering Period to be effective during that Offering Period.  If you decrease your percentage to 0%, any previously accumulated contributions will be used to purchase shares on the next Purchase Date pursuant to Section 9 of the ESPP.  A change will become effective as soon as reasonably practicable after the form is received by the Company.  

	
			
	SECTION 5:
WITHDRAW FROM PLAN / OPT OUT

	DO NOT CHECK ANY OF THE BOXES BELOW IF YOU WISH TO CONTINUE TO PARTICIPATE IN THE ESPP 
o  I understand that my enrollment in the ESPP was automatically effective at the beginning of the Offering Period.  I hereby elect to withdraw from the ESPP.
Note:   No contributions will be made if you elect to opt out of the ESPP.  I understand that I cannot resume participation until the start of the next Offering Period and must timely file a new enrollment form to do so.  

	
			
	SECTION 6:
NATURE OF GRANT

	By continuing my automatic enrollment in the ESPP, I understand, acknowledge and agree that (a) the ESPP is established voluntarily by the Company, it is discretionary in nature and it may be amended, terminated or modified at any time, to the extent permitted by the ESPP; (b) the grant of the right to purchase shares of Common Stock under the ESPP is voluntary and does not create any contractual or other right to receive future rights to purchase shares of Common Stock, or benefits in lieu of rights to purchase shares, even if rights to purchase shares have been granted in the past; (c) all decisions with respect to future grants of rights to purchase shares of Common Stock under the ESPP, if any, will be at the sole discretion of the Company; (d) the grant of rights to purchase shares of Common Stock under the ESPP and my participation in the ESPP shall not create a right to employment or be interpreted as forming an employment or service agreement with the Company; (e) the grant of rights to purchase shares of Common Stock under the ESPP and my participation in the ESPP shall not interfere with the ability of the Employer to terminate my employment relationship at any time with or without cause; (f) I am voluntarily participating in the ESPP; (g) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not intended to replace any pension rights or compensation; (h) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not part of normal or expected compensation for purposes of, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; (i) unless otherwise agreed with the Company, the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not granted as consideration for, or in connection with, any service I may provide as a director of the Subsidiary or Affiliate; (j) the future value of the underlying shares purchased or to be purchased under the ESPP is unknown, indeterminable and cannot be predicted with certainty, and the value of the shares of Common Stock purchased under the ESPP may increase or decrease in the future, even below the Purchase Price; (k) no claim or entitlement to compensation or damages shall arise from termination of the right to purchase shares of Common Stock under the ESPP resulting from termination of my employment (for any reason whatsoever and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any) and in consideration of the grant of rights to purchase shares of Common Stock under the ESPP, I irrevocably agree never to institute any claim against the Company, the Parent, the Employer or any other Subsidiary or Affiliate, I hereby waive my ability, if any, to bring any such claim, and I release the Company, the Parent, the Employer or any other Subsidiary or Affiliate from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by enrolling in the ESPP, I shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claims; (l) in the event of termination of my employment (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any), my right to participate in the ESPP and my right to purchase shares of Common Stock, if any, will terminate effective as of the date I cease to actively provide services and will not be extended by any notice period (e.g., employment would not include any contractual notice or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any); the Committee shall have exclusive discretion to determine when I am no longer actively employed for purposes of my participation in the ESPP (including whether I may still be considered to be providing services while on a leave of absence); (m) unless otherwise provided in the ESPP or by the Company in its discretion, the right to purchase shares of Common Stock and the benefits evidenced by this Enrollment/Change Form do not create any entitlement to have the ESPP or any such benefits granted thereunder transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Common Stock; and (n) if I am providing services outside the United States: (1) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not part of normal or expected compensation or salary for any purpose, and (2) neither the Company, the Parent, the Employer nor any other Subsidiary or Affiliate shall be liable for any foreign exchange rate fluctuation between my local currency and the United States Dollar that may affect the value of the rights to purchase shares of Common Stock, the shares purchased under the ESPP or any amounts due to me pursuant to the sale of any shares of Common Stock acquired under the ESPP.

	
			
	SECTION 7:
DATA PRIVACY

	I hereby explicitly, voluntarily and unambiguously consent to the collection, use and transfer, in electronic or other form, of my personal data as described in this Enrollment/Change Form and any other ESPP grant materials by and among, as applicable, the Employer, the Company, the Parent and any of its other Subsidiaries or Affiliates or any third parties assisting in the implementation, administration and management of my participation in the ESPP.  
I understand that the Company and the Employer may hold certain personal information about me, including, but not limited to, my name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, the fact and conditions of my participation in the ESPP, details of all rights to purchase shares or any other entitlement to shares of Common Stock awarded, cancelled, exercised, vested, unvested or outstanding in my favor (“Data”), for the exclusive purpose of implementing, administering and managing the ESPP.
I also authorize any transfer of Data, as may be required, to the stock plan service provider that may be designated by the Company from time to time, which is assisting the Company with the implementation, administration and management of the ESPP and/or with whom any shares of Common Stock acquired under the ESPP are deposited.  I acknowledge that these recipients may be located in my country or elsewhere, and that the recipient’s country (e.g., the United States) may have different data privacy laws and protections to my country, which may not give the same level of protection to Data.  I understand that, if I reside outside the United States, I may request a list with the names and addresses of any potential recipients of Data by contacting my local human resources representative. I authorize the Company, the designated broker and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing my participation in the ESPP to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of implementing, administering and managing my participation in the ESPP.  I understand that Data will be held only as long as is necessary to implement, administer and manage my participation in the ESPP. I understand that, if I reside outside the United States, I may at any time view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case, without cost, by contacting in writing my local human resources representative.  Further, I understand that I am providing the consents herein on a purely voluntary basis.  If I do not consent, or if I later seek to revoke my consent, my employment status or service and career with the Company and/or the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing my consent is that the Company would not be able to grant future rights to purchase shares of Common Stock or other equity awards to me or administer or maintain such awards.  Therefore, I understand that refusing or withdrawing my consent may affect my ability to participate in the ESPP.  For more information on the consequences of my refusal to consent or withdrawal of consent, I understand that I may contact my local human resources representative.  

	
			
	SECTION 8:
RESPONSIBILITY FOR TAXES
	I acknowledge that, regardless of any action taken by the Company or the Employer, the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to my participation in the ESPP and legally applicable to me (“Tax-Related Items”) is and remains my responsibility and may exceed the amount actually withheld by the Company or the Employer.  I further acknowledge that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the ESPP, including, but not limited to, my enrollment in the ESPP, the grant of rights to purchase shares of Common Stock, the purchase of shares of Common Stock, the issuance of Common Stock purchased, the sale of shares of Common Stock purchased under the ESPP or the receipt of any dividends; and (2) do not commit to and are under no obligation to structure the terms of the ESPP to reduce or eliminate my liability for Tax-Related Items or achieve any particular tax result.  Further, if I am subject to Tax-Related Items in more than one jurisdiction, I acknowledge that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
Prior to any relevant taxable or tax withholding event, as applicable, I agree to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items.  In this regard, I authorize the Company and/or the Employer to satisfy their withholding obligations with regard to all Tax-Related Items by one or a combination of the following: (a) withholding from my wages or other cash compensation payable to me by the Company and/or the Employer, (b) withholding from proceeds of the sale of shares of Common Stock purchased under the ESPP, either through a voluntary sale or through a mandatory sale arranged by the Company (on my behalf pursuant to this authorization without further consent), and (c) withholding in shares to be issued upon purchase under the ESPP.  
Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates, including up to the maximum permissible statutory rates, in which case I will receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, I am deemed to have been issued the full number of shares of Common Stock, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.
Finally, I agree to pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of my participation in the ESPP that cannot be satisfied by the means previously described.  The Company may refuse to purchase or deliver the shares or the proceeds from the sale of shares of Common Stock, if I fail to comply with my obligations in connection with the Tax-Related Items.

	SECTION 9:
GOVERNING LAW  & LANGUAGE
	The rights to purchase shares and the provisions of this Enrollment/Change Form are governed by, and subject to, the laws of the State of Delaware, without regard to any conflict of law provisions.  If I have received this or any other document related to the ESPP translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

	SECTION 10:
APPENDIX & IMPOSITION OF OTHER REQUIREMENTS
	Notwithstanding any provision herein, my participation in the ESPP shall be subject to any special terms and conditions as set forth in the Appendix for my country, if any.  Moreover, if I relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to me, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  The Appendix constitutes part of this Enrollment/Change Form.
The Company reserves the right to impose other requirements on my participation in the ESPP or on any shares of Common Stock purchased under the ESPP, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require me to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

	
			
	SECTION 11:
ELECTRONIC DELIVERY AND ACCEPTANCE
	The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the ESPP by electronic means.  I hereby consent to receive such documents by electronic delivery and agree to participate in the ESPP through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

	SECTION 12:
SEVERABILITY & WAIVER
	The provisions of this Enrollment/Change Form are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.  I acknowledge that a waiver by the Company of breach of any provision of this Enrollment/Change Form shall not operate or be construed as a waiver of any other provision herein, or of any subsequent breach by me or any other Participant.

	SECTION 13:
INSIDER TRADING RESTRICTIONS / MARKET ABUSE LAWS
	I acknowledge that I may be subject to insider trading restrictions and/or market abuse laws, which may affect my ability to acquire or sell shares of Common Stock or my rights to purchase shares under the ESPP during such times as I am considered to have “inside information” regarding the Company (as defined by or determined under the laws in my country).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  I acknowledge that it is my responsibility to comply with any applicable restrictions, and that I am advised to speak to my personal advisor on this matter.

	SECTION 14: 
NO ADVICE REGARDING GRANT
	The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding my participation in the ESPP, or my purchase or sale of the shares of Common Stock.  I am hereby advised to consult with my own personal tax, legal and financial advisors regarding my participation in the ESPP before taking any action related to the ESPP.

	SECTION 15: 
COMPLIANCE WITH LAW
	Unless there is an available exemption from any registration, qualification or other legal requirement applicable to the shares of Common Stock, the Company shall not be required to deliver any shares under the ESPP prior to the completion of any registration or qualification of the shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S. Securities and Exchange Commission (“SEC”) or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable.  I understand that the Company is under no obligation to register or qualify the shares with the SEC or any state or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the shares.  Further, I agree that the Company shall have unilateral authority to amend the ESPP and the Enrollment/Change Form without my consent to the extent necessary to comply with securities or other laws applicable to issuance of shares. 

	SECTION 16:
ACKNOWLEDGMENT AND SIGNATURE
	I acknowledge that I have received a copy of the ESPP Prospectus (which summarizes the major features of the ESPP).  I have read the Prospectus and my signature below indicates that I hereby agree to be bound by the terms of the ESPP.  
Signature:                                                                   Date:                                       

APPENDIX
CLOUDERA, INC.
2017 EMPLOYEE STOCK PURCHASE PLAN
GLOBAL ENROLLMENT/CHANGE FORM
COUNTRY SPECIFIC PROVISIONS FOR EMPLOYEES OUTSIDE THE U.S.

Capitalized terms used but not defined herein shall have the meanings ascribed to them in the ESPP or the Enrollment/Change Form.
TERMS AND CONDITIONS
This Appendix includes additional terms and conditions that govern your participation in the Cloudera, Inc. 2017 Employee Stock Purchase Plan if you reside and/or work in one of the countries listed below.  If you are a citizen or resident (or are considered as such for local law purposes) of a country other than the country in which you are currently residing and/or working, or if you transfer to another country after enrolling in the ESPP, the Company shall, in its discretion, determine to what extent the special terms and conditions contained herein shall be applicable to you.
NOTIFICATIONS 
This Appendix also includes information regarding securities, exchange controls, tax and certain other issues of which you should be aware with respect to your participation in the ESPP.  The information is based on the securities, exchange control, tax and other laws in effect in your country as of [_____].  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you not rely on the information in this Appendix as the only source of information relating to the consequences of your participation in the ESPP because the information may be out of date at the time you exercise your right to purchase shares or sell shares of Common Stock purchased under the ESPP.
In addition, the information contained herein is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of any particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your situation.
Finally, if you are a citizen or resident of a country, or are considered resident of a country, other than the one in which you are currently residing and/or working, or you transfer employment and/or residency after you enroll in the ESPP, the information contained herein may not be applicable to you.  

[JURISDICTIONS TO BE PROVIDED, AS APPLICABLE.]

	
		
	CLOUDERA, INC. (THE “COMPANY”)
2017 EMPLOYEE STOCK PURCHASE PLAN 
	ENROLLMENT/CHANGE FORM

	
			
	SECTION 1:
ACTIONS
	CHECK DESIRED ACTION:                      AND COMPLETE SECTIONS:
 o  Enroll in the ESPP                                                 2 + 3 + 4 + 16
 o  Elect / Change Contribution Percentage               2 + 4 + 16
 o  Withdraw from Plan                                              2 + 5 + 16

	SECTION 2:
PERSONAL DATA
	Name:                                                                                          
Home Address:                                                                            
                                                                                                     
Work Email:                                                                                
	Employee ID:
                              

	SECTION 3:
ENROLL
	o   I hereby elect to participate in the 2017 Employee Stock Purchase Plan, together with any sub-plan thereto for my country of residence (if any) (the “Sub-Plan”) (together, the “ESPP”), effective at the beginning of the next Offering Period (as defined in the ESPP).  I elect to purchase shares of Common Stock of the Company pursuant to the ESPP, this Enrollment/Change Form and any appendix to this Enrollment/Change Form for my country (if any) (the “Appendix”).  I understand that the shares purchased on my behalf will be issued in street name and deposited directly into my brokerage account at the Company’s captive broker.  I hereby agree to take all steps, and sign all forms, required to establish an account with the Company’s captive broker for this purpose.
My participation will continue as long as I remain eligible, unless I withdraw from the ESPP by filing a new Enrollment/Change Form with the Company or the Third Party Administrator (as defined in the ESPP).  I understand that, if I am subject to tax in the U.S., I must notify the Company of any disposition of shares purchased under the ESPP.

	SECTION 4:
ELECT/CHANGE CONTRIBUTION PERCENTAGE
	I hereby authorize the Company or the Parent, Subsidiary or Affiliate employing me (the “Employer”) to withhold from each of my paychecks such amount as is necessary to equal at the end of the applicable Offering Period the percentage of my Compensation (as defined in the ESPP) paid to me during such Offering Period as indicated below, so long as I continue to participate in the ESPP.  The percentage must be a whole number (from 1%, up to a maximum of 15%, with respect to enrollment or an increase in contribution percentage; and from 0%, up to a maximum of 14%, for a decrease in contribution percentage).
Designated contribution percentage:  _____%
If this is a change to my current enrollment, this represents an  increase  decrease to my contribution percentage.
Note:   You may not increase your contributions at any time within an on-going Offering Period.  An increase in your contribution percentage can only take effect with the next Offering Period.  You may decrease your previously elected contribution percentage only once within an on-going Offering Period to be effective during that Offering Period. If you decrease your percentage to 0%, any previously accumulated contributions will be used to purchase shares on the next Purchase Date pursuant to Section 9 of the ESPP.  A change will become effective as soon as reasonably practicable after the form is received by the Company.

	SECTION 5:
WITHDRAW FROM PLAN
	o I hereby elect to withdraw from, and discontinue my participation in, the ESPP, effective as soon as reasonably practicable after this form is received by the Company.  Accumulated contributions will be returned to me without interest (except to the extent required due to local legal requirements outside the United States), pursuant to Section 11 of the ESPP. 

	
			
	SECTION 6:
NATURE OF GRANT
	By enrolling in the ESPP, I understand, acknowledge and agree that (a) the ESPP is established voluntarily by the Company, it is discretionary in nature and it may be amended, terminated or modified at any time, to the extent permitted by the ESPP; (b) the grant of the right to purchase shares of Common Stock under the ESPP is voluntary and does not create any contractual or other right to receive future rights to purchase shares of Common Stock, or benefits in lieu of rights to purchase shares, even if rights to purchase shares have been granted in the past; (c) all decisions with respect to future grants of rights to purchase shares of Common Stock under the ESPP, if any, will be at the sole discretion of the Company; (d) the grant of rights to purchase shares of Common Stock under the ESPP and my participation in the ESPP shall not create a right to employment or be interpreted as forming an employment or service agreement with the Company; (e) the grant of rights to purchase shares of Common Stock under the ESPP and my participation in the ESPP shall not interfere with the ability of the Employer to terminate my employment relationship at any time with or without cause; (f) I am voluntarily participating in the ESPP; (g) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not intended to replace any pension rights or compensation; (h) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not part of normal or expected compensation for purposes of, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; (i) unless otherwise agreed with the Company, the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not granted as consideration for, or in connection with, any service I may provide as a director of the Subsidiary or Affiliate; (j) the future value of the underlying shares purchased or to be purchased under the ESPP is unknown, indeterminable and cannot be predicted with certainty, and the value of the shares of Common Stock purchased under the ESPP may increase or decrease in the future, even below the Purchase Price; (k) no claim or entitlement to compensation or damages shall arise from termination of the right to purchase shares of Common Stock under the ESPP resulting from termination of my employment (for any reason whatsoever and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any) and in consideration of the grant of rights to purchase shares of Common Stock under the ESPP, I irrevocably agree never to institute any claim against the Company, the Parent, the Employer or any other Subsidiary or Affiliate, I hereby waive my ability, if any, to bring any such claim, and I release the Company, the Parent, the Employer or any other Subsidiary or Affiliate from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by enrolling in the ESPP, I shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claims; (l) in the event of termination of my employment (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any), my right to participate in the ESPP and my right to purchase shares of Common Stock, if any, will terminate effective as of the date I cease to actively provide services and will not be extended by any notice period (e.g., employment would not include any contractual notice or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where I am employed or the terms of my employment agreement, if any); the Committee shall have exclusive discretion to determine when I am no longer actively employed for purposes of my participation in the ESPP (including whether I may still be considered to be providing services while on a leave of absence); (m) unless otherwise provided in the ESPP or by the Company in its discretion, the right to purchase shares of Common Stock and the benefits evidenced by this Enrollment/Change Form do not create any entitlement to have the ESPP or any such benefits granted thereunder transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any Corporate Transaction affecting the Common Stock; and (n) if I am providing services outside the United States: (1) the rights to purchase shares of Common Stock and the shares purchased under the ESPP, and the income and value of same, are not part of normal or expected compensation or salary for any purpose, and (2) neither the Company, the Parent, the Employer nor any other Subsidiary or Affiliate shall be liable for any foreign exchange rate fluctuation between my local currency and the United States Dollar that may affect the value of the rights to purchase shares of Common Stock, the shares purchased under the ESPP or any amounts due to me pursuant to the sale of any shares of Common Stock acquired under the ESPP.

	
			
	SECTION 7:
DATA PRIVACY
	I hereby explicitly, voluntarily and unambiguously consent to the collection, use and transfer, in electronic or other form, of my personal data as described in this Enrollment/Change Form and any other ESPP grant materials by and among, as applicable, the Employer, the Company, the Parent and any of its other Subsidiaries or Affiliates or any third parties assisting in the implementation, administration and management of my participation in the ESPP.  
I understand that the Company and the Employer may hold certain personal information about me, including, but not limited to, my name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, the fact and conditions of my participation in the ESPP, details of all rights to purchase shares or any other entitlement to shares of Common Stock awarded, cancelled, exercised, vested, unvested or outstanding in my favor (“Data”), for the exclusive purpose of implementing, administering and managing the ESPP.
I also authorize any transfer of Data, as may be required, to the stock plan service provider that may be designated by the Company from time to time, which is assisting the Company with the implementation, administration and management of the ESPP and/or with whom any shares of Common Stock acquired under the ESPP are deposited.  I acknowledge that these recipients may be located in my country or elsewhere, and that the recipient’s country (e.g., the United States) may have different data privacy laws and protections to my country, which may not give the same level of protection to Data.  I understand that, if I reside outside the United States, I may request a list with the names and addresses of any potential recipients of Data by contacting my local human resources representative. I authorize the Company, the designated broker and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing my participation in the ESPP to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of implementing, administering and managing my participation in the ESPP.  I understand that Data will be held only as long as is necessary to implement, administer and manage my participation in the ESPP. I understand that, if I reside outside the United States, I may at any time view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case, without cost, by contacting in writing my local human resources representative.  Further, I understand that I am providing the consents herein on a purely voluntary basis.  If I do not consent, or if I later seek to revoke my consent, my employment status or service and career with the Company and/or the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing my consent is that the Company would not be able to grant future rights to purchase shares of Common Stock or other equity awards to me or administer or maintain such awards.  Therefore, I understand that refusing or withdrawing my consent may affect my ability to participate in the ESPP.  For more information on the consequences of my refusal to consent or withdrawal of consent, I understand that I may contact my local human resources representative.  

	
			
	SECTION 8:
RESPONSIBILITY FOR TAXES
	I acknowledge that, regardless of any action taken by the Company or the Employer, the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to my participation in the ESPP and legally applicable to me (“Tax-Related Items”) is and remains my responsibility and may exceed the amount actually withheld by the Company or the Employer.  I further acknowledge that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the ESPP, including, but not limited to, my enrollment in the ESPP, the grant of rights to purchase shares of Common Stock, the purchase of shares of Common Stock, the issuance of Common Stock purchased, the sale of shares of Common Stock purchased under the ESPP or the receipt of any dividends; and (2) do not commit to and are under no obligation to structure the terms of the ESPP to reduce or eliminate my liability for Tax-Related Items or achieve any particular tax result.  Further, if I am subject to Tax-Related Items in more than one jurisdiction, I acknowledge that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
Prior to any relevant taxable or tax withholding event, as applicable, I agree to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items.  In this regard, I authorize the Company and/or the Employer to satisfy their withholding obligations with regard to all Tax-Related Items by one or a combination of the following: (a) withholding from my wages or other cash compensation payable to me by the Company and/or the Employer, (b) withholding from proceeds of the sale of shares of Common Stock purchased under the ESPP, either through a voluntary sale or through a mandatory sale arranged by the Company (on my behalf pursuant to this authorization without further consent), and (c) withholding in shares to be issued upon purchase under the ESPP.  
Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates, including up to the maximum permissible statutory rates, in which case I will receive a refund of any over-withheld amount in cash and will have no entitlement to the Common Stock equivalent.  If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, I am deemed to have been issued the full number of shares of Common Stock, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.
Finally, I agree to pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of my participation in the ESPP that cannot be satisfied by the means previously described.  The Company may refuse to purchase or deliver the shares or the proceeds from the sale of shares of Common Stock, if I fail to comply with my obligations in connection with the Tax-Related Items.

	SECTION 9:
GOVERNING LAW & LANGUAGE
	The rights to purchase shares and the provisions of this Enrollment/Change Form are governed by, and subject to, the laws of the State of Delaware, without regard to any conflict of law provisions.  
If I have received this or any other document related to the ESPP translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.

	
			
	SECTION 10:
APPENDIX & IMPOSITION OF OTHER REQUIREMENTS
	Notwithstanding any provision herein, my participation in the ESPP shall be subject to any special terms and conditions as set forth in the Appendix for my country, if any.  Moreover, if I relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to me, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.  The Appendix constitutes part of this Enrollment/Change Form.
The Company reserves the right to impose other requirements on my participation in the ESPP or on any shares of Common Stock purchased under the ESPP, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require me to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

	SECTION 11:
ELECTRONIC DELIVERY AND ACCEPTANCE
	The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the ESPP by electronic means.  I hereby consent to receive such documents by electronic delivery and agree to participate in the ESPP through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

	SECTION 12:
SEVERABILITY & WAIVER
	The provisions of this Enrollment/Change Form are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.  I acknowledge that a waiver by the Company of breach of any provision of this Enrollment/Change Form shall not operate or be construed as a waiver of any other provision herein, or of any subsequent breach by me or any other Participant.

	SECTION 13:
INSIDER TRADING RESTRICTIONS/MARKET ABUSE LAWS
	I acknowledge that I may be subject to insider trading restrictions and/or market abuse laws, which may affect my ability to acquire or sell shares of Common Stock or my rights to purchase shares under the ESPP during such times as I am considered to have “inside information” regarding the Company (as defined by or determined under the laws in my country).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  I acknowledge that it is my responsibility to comply with any applicable restrictions, and that I am advised to speak to my personal advisor on this matter.

	SECTION 14: 
NO ADVICE REGARDING GRANT
	The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding my participation in the ESPP, or my purchase or sale of the shares of Common Stock.  I am hereby advised to consult with my own personal tax, legal and financial advisors regarding my participation in the ESPP before taking any action related to the ESPP.

	SECTION 15: 
COMPLIANCE WITH LAW
	Unless there is an available exemption from any registration, qualification or other legal requirement applicable to the shares of Common Stock, the Company shall not be required to deliver any shares under the ESPP prior to the completion of any registration or qualification of the shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S. Securities and Exchange Commission (“SEC”) or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable.  I understand that the Company is under no obligation to register or qualify the shares with the SEC or any state or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the shares.  Further, I agree that the Company shall have unilateral authority to amend the ESPP and the Enrollment/Change Form without my consent to the extent necessary to comply with securities or other laws applicable to issuance of shares. 

	SECTION 16:
ACKNOWLEDGMENT AND SIGNATURE
	I acknowledge that I have received a copy of the ESPP Prospectus (which summarizes the major features of the ESPP).  I have read the Prospectus and my signature below indicates that I hereby agree to be bound by the terms of the ESPP.
Signature:                                                                   Date:                                       

APPENDIX
CLOUDERA, INC.
2017 EMPLOYEE STOCK PURCHASE PLAN
GLOBAL ENROLLMENT/CHANGE FORM
COUNTRY SPECIFIC PROVISIONS FOR EMPLOYEES OUTSIDE THE U.S.

Capitalized terms used but not defined herein shall have the meanings ascribed to them in the ESPP or the Enrollment/Change Form.
TERMS AND CONDITIONS
This Appendix includes additional terms and conditions that govern your participation in the Cloudera, Inc. 2017 Employee Stock Purchase Plan if you reside and/or work in one of the countries listed below.  If you are a citizen or resident (or are considered as such for local law purposes) of a country other than the country in which you are currently residing and/or working, or if you transfer to another country after enrolling in the ESPP, the Company shall, in its discretion, determine to what extent the special terms and conditions contained herein shall be applicable to you.
NOTIFICATIONS 
This Appendix also includes information regarding securities, exchange controls, tax and certain other issues of which you should be aware with respect to your participation in the ESPP.  The information is based on the securities, exchange control, tax and other laws in effect in your country as of [_____].  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you not rely on the information in this Appendix as the only source of information relating to the consequences of your participation in the ESPP because the information may be out of date at the time you exercise your right to purchase shares or sell shares of Common Stock purchased under the ESPP.
In addition, the information contained herein is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of any particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your situation.
Finally, if you are a citizen or resident of a country, or are considered resident of a country, other than the one in which you are currently residing and/or working, or you transfer employment and/or residency after you enroll in the ESPP, the information contained herein may not be applicable to you.  

[JURISDICTIONS TO BE PROVIDED, AS APPLICABLE.]Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE
AGREEMENT (the “Agreement”) is dated as of the 4th day of April 2017, by and among theMaven, Inc., a Delaware
corporation (the “Company”), MDB Capital Group, LLC, a Texas limited liability company (the “Placement
Agent”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity,
individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).

 

RECITALS

 

A.           
Subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933,
as amended (the “Securities Act”), and Rule 506(b) promulgated thereunder, the Company desires to issue and
sell to each Buyer, and each Buyer, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement.

 

B.           In
connection with the offering of Shares contemplated by this Agreement (the “Offering”), the Company and the
Placement Agent have entered into a letter agreement (the “Engagement Letter”) pursuant to which, among other
things, the Placement Agent is entitled to receive certain Shares as partial consideration for its services to the Company in connection
with the Offering.

 

AGREEMENT

 

NOW, THEREFORE, in consideration
of the premises and the mutual covenants of the parties hereinafter expressed and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties hereto, each intending to be legally bound, agree as follows:

 

ARTICLE
I

RECITALS, EXHIBITS, SCHEDULES

 

The foregoing recitals
are true and correct and, together with the Schedules and Exhibits referred to hereafter, are hereby incorporated into this Agreement
by this reference.

 

ARTICLE
II

DEFINITIONS

 

For purposes of this Agreement,
except as otherwise expressly provided or otherwise defined elsewhere in this Agreement, or unless the context otherwise requires,
the capitalized terms in this Agreement shall have the meanings assigned to them in this Article as follows:

 

2.1           “Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

     

     

    

 

2.2           “Assets”
means all of the properties and assets of the Company and its Operating Subs, whether real, personal or mixed, tangible or intangible,
wherever located, whether now owned or hereafter acquired.

 

2.3           “Buyer’s
Purchase Price” shall mean, with respect to any Buyer, the “Purchase Price” opposite such Buyer’s name
on the Schedule of Buyers.

 

2.4           “Claims”
means any Proceedings, Judgments, Obligations, known threats, losses, damages, deficiencies, settlements, assessments, charges,
costs and expenses of any nature or kind.

 

2.5           “Common
Stock” means the Company’s common stock, $0.01 par value per share.

 

2.6           “Consent”
means any consent, approval, order or authorization of, or any declaration, filing or registration with, or any application or
report to, or any waiver by, or any other action (whether similar or dissimilar to any of the foregoing) of, by or with, any Person,
which is necessary in order to take a specified action or actions, in a specified manner and/or to achieve a specific result.

 

2.7           “Contract”
means any written contract, agreement, order or commitment of any nature whatsoever, including, any sales order, purchase order,
lease, sublease, license agreement, services agreement, loan agreement, mortgage, security agreement, guarantee, management contract,
employment agreement, consulting agreement, partnership agreement, shareholders agreement, buy-sell agreement, option, warrant,
debenture, subscription, call or put.

 

2.8           “Encumbrance”
means any lien, security interest, pledge, mortgage, easement, leasehold, assessment, tax, covenant, restriction, reservation,
conditional sale, prior assignment, or any other encumbrance, claim, burden or charge of any nature whatsoever.

 

2.9           “Environmental
Requirements” means all Laws and requirements relating to human, health, safety or protection of the environment or to
emissions, discharges, releases or threatened releases of pollutants, contaminants, or Hazardous Materials in the environment (including,
without limitation, ambient air, surface water, ground water, land surface or subsurface strata), or otherwise relating to the
treatment, storage, disposal, transport or handling of any Hazardous Materials.

 

2.10         “Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

2.11         “GAAP”
means generally accepted accounting principles, methods and practices set forth in the opinions and pronouncements of the Accounting
Principles Board and the American Institute of Certified Public Accountants, and statements and pronouncements of the Financial
Accounting Standards Board, the SEC or of such other Person as may be approved by a significant segment of the U.S. accounting
profession, in each case as of the date or period at issue, and as applied in the U.S. to U.S. companies.

 

    	 	2	 

     

    

 

2.12         “Governmental
Authority” means any foreign, federal, state or local government, or any political subdivision thereof, or any court,
agency or other body, organization, group, stock market or exchange exercising any executive, legislative, judicial, quasi-judicial,
regulatory or administrative function of government.

 

2.13         “Hazardous
Materials” means: (i) any petroleum or petroleum products, radioactive materials, asbestos in any form that is or could
become friable, urea formaldehyde foam insulation and transformers or other equipment that contain dielectric fluid containing
levels of polychlorinated biphenyls (PCB’s); (ii) any chemicals, materials, substances or wastes which are now or hereafter
become defined as or included in the definition of “hazardous substances,” “hazardous wastes,” “hazardous
materials,” “extremely hazardous wastes,” “restricted hazardous wastes,” “toxic substances,”
“toxic pollutants” or words of similar import, under any Law; and (iii) any other chemical, material, substance, or
waste, exposure to which is now or hereafter prohibited, limited or regulated by any Governmental Authority.

 

2.14         “Judgment”
means any final order, writ, injunction, fine, citation, award, decree, or any other judgment of any nature whatsoever of any Governmental
Authority.

 

2.15         “Law”
means any provision of any law, statute, ordinance, code, constitution, charter, treaty, rule or regulation of any Governmental
Authority applicable to the Company.

 

2.16         “Leases”
means all leases for real or personal property.

 

2.17         “Material
Adverse Effect” means with respect to the event, item or question at issue, that such event, item or question would not
have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of this
Agreement or any of the Transaction Documents; (ii) a material adverse effect on the results of operations, Assets, business or
condition (financial or otherwise) of the Company and its subsidiaries, taken as a whole; or (iii) a material adverse effect on
the Company’s or its subsidiaries’ ability to perform, on a timely basis, its or their respective Obligations under
this Agreement or any Transaction Documents.

 

2.18         “Material
Contract” means any Contract to which the Company or any subsidiary thereof is a party or by which they or their respective
assets is bound which is required to be filed as an exhibit to the Company’s filings with the SEC pursuant to Item 601(b)(4)
or Item 601(b)(10) of Regulation S-K promulgated by the SEC, and by its terms has current obligations to be performed by the parties
thereto, without regard to any statute of limitations periods during which an obligation may be enforced.

 

2.19         “Obligation”
means any debt, liability or obligation of any nature whatsoever, whether secured, unsecured, recourse, nonrecourse, liquidated,
unliquidated, accrued, absolute, fixed, contingent, ascertained, unascertained, known or unknown, or obligations under executory
Contracts.

 

2.20         “Ordinary
Course of Business” means the ordinary course of business of the Company consistent with its past custom and practice
since November 7, 2016 (including with respect to quantity, quality and frequency).

 

    	 	3	 

     

    

 

2.21         “Permit”
means any license, permit, approval, waiver, order, authorization, right or privilege of any nature whatsoever, granted, issued,
approved or allowed by any Governmental Authority.

 

2.22         “Person”
means any individual, sole proprietorship, joint venture, partnership, company, corporation, association, limited liability company,
cooperation, trust, estate, Governmental Authority, or any other entity of any nature whatsoever.

 

2.23         “Principal
Trading Market” shall mean the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the
OTC Markets, including the Bulletin Board and Pink Sheets, the NYSE Euronext or the New York Stock Exchange, whichever is at the
time the principal trading exchange or market for the Common Stock.

 

2.24         “Proceeding”
means any demand, claim, suit, action, litigation, investigation, audit, study, arbitration, administrative hearing, or any other
proceeding of any nature whatsoever.

 

2.25         “Real
Property” means any real estate, land, building, structure, improvement, fixture or other real property of any nature
whatsoever, including, but not limited to, fee and leasehold interests.

 

2.26         “Registration
Rights Agreement” means the Registration Rights Agreement, dated the date hereof, among the Company and the Buyers, in
the form of Exhibit A attached hereto.

 

2.27         “SEC”
means the United States Securities and Exchange Commission.

 

2.28         “Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

2.29         “Tax”
means (i) any foreign, federal, state or local income, profits, gross receipts, franchise, sales, use, occupancy, general property,
real property, personal property, intangible property, transfer, fuel, excise, accumulated earnings, personal holding company,
unemployment compensation, social security, withholding taxes, payroll taxes, or any other tax of any nature whatsoever, (ii) any
foreign, federal, state or local organization fee, qualification fee, annual report fee, filing fee, occupation fee, assessment,
rent, or any other fee or charge of any nature whatsoever, or (iii) any deficiency, interest or penalty imposed with respect to
any of the foregoing.

 

2.30         “Tax
Return” means any tax return, filing, declaration, information statement or other form or document required to be filed
in connection with or with respect to any Tax.

 

2.31         “Transaction
Documents” means this Agreement, the Registration Rights Agreement and the Engagement Letter, executed in connection
with the transactions contemplated hereunder.

 

    	 	4	 

     

    

 

ARTICLE
III

INTERPRETATION

 

In this Agreement, unless
the express context otherwise requires: (i) the words “herein,” “hereof” and “hereunder” and
words of similar import refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii) references
to the words “Article” or “Section” refer to the respective Articles and Sections of this Agreement, and
references to “Exhibit” or “Schedule” refer to the respective Exhibits and Schedules annexed hereto; (iii)
references to a “party” mean a party to this Agreement and include references to such party’s permitted successors
and permitted assigns; (iv) references to a “third party” mean a Person not a party to this Agreement; (v) the terms
“dollars” and “$” means U.S. dollars; (vi) wherever the word “include,” “includes”
or “including” is used in this Agreement, it will be deemed to be followed by the words “without limitation.”

 

ARTICLE
IV

PURCHASE AND SALE

 

4.1           Sale
and Issuance of Shares.

 

(a)          Subject
to the terms and conditions of this Agreement, each Buyer agrees, severally and not jointly, to subscribe for and purchase, and
upon acceptance by the Company of each such subscription, it agrees to sell and issue to each Buyer, the number of shares of Common
Stock (the “Shares” or sometimes referred to as the “Securities”) set forth on the signature
page to this Agreement. The Shares purchased shall be sold at a cash purchase price of $1.00 per Share (the “Purchase
Price”). The Company’s agreement with each Buyer is a separate agreement, and the sale and issuance of the Shares
to each Buyer is a separate sale and issuance from all other sales and issuances to other Buyers who purchase Securities in this
Offering.

 

(b)          Upon
each and every sale of Securities by the Company, it will pay to the Placement Agent a cash fee of 5% of the gross Purchase Price
paid by each Buyer (the “Cash Fee”). In addition to the Cash Fee, upon each sale of Securities to Buyers who
are also MDB Investors (as defined in the Engagement Letter), the Company shall issue to the Placement Agent, for no additional
consideration and pursuant to the terms of the Engagement Letter, a number of Shares equal to (x) the aggregate number of Shares
being acquired by such MDB Investors, multiplied by (y) 5.0%, rounded down to the nearest whole Share.

 

4.2           Subscription
Acceptance. The Shares are being sold on a rolling basis, which means that the Company may accept a subscription for the sale
of Shares to one or more Buyers from time to time, individually or in groups of subscriptions. The Purchase Price will be paid
into the accounts of the Company, not into an escrow or other segregated account, at the time of each Buyer’s subscription
and payment for Shares issued and sold by the Company pursuant to this Agreement. The funds paid by the Buyers to the Company pursuant
to the terms of this Agreement will be subject to the creditors of the Company upon payment by the Buyer to the Company, even if
the subscription is not yet accepted by the Company. Each subscription will be irrevocable once submitted by each Buyer; provided,
however, that the Company may reject any subscription of any Buyer in the Company’s sole discretion. If the Company rejects
a subscription from a Buyer, it will return the Purchase Price paid in respect thereof promptly, without deduction or interest.
The purchase, sale and issuance of the Shares pursuant to this Agreement shall take place at the offices of Golenbock Eiseman Assor
Bell & Peskoe LLP, 711 Third Avenue, New York, New York 10017, or such other location as the parties shall mutually agree,
no later than the second business day following the satisfaction or waiver of the conditions provided in Articles VIII and IX of
this Agreement.

 

    	 	5	 

     

    

 

4.3           Form
of Payment; Delivery. Substantially concurrently with the delivery of an executed copy of this Agreement to the Company, the
Buyer purchasing and subscribing for Shares shall deliver to the Company, for deposit in an account designated by the Company,
the Buyer’s Purchase Price against delivery of the Shares being issued and sold.

 

ARTICLE
V

BUYERS’ REPRESENTATIONS
AND WARRANTIES

 

Each Buyer represents and warrants to the Company
and the Placement Agent, severally and not jointly, that:

 

5.1           Investment
Purpose. Such Buyer is acquiring the Securities for his, her or its own account, for investment only, and not with a view towards
or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered or exempted under
the Securities Act; provided, however, that by making the representations herein, such Buyer reserves the right to dispose of the
Securities at any time in accordance with or pursuant to an effective registration statement covering such Securities or an available
exemption under the Securities Act. Such Buyer acknowledges that a legend will be placed on the certificates representing the Securities
in the following form:

 

THESE SECURITIES
HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND ARE “RESTRICTED
SECURITIES” AS THAT TERM IS DEFINED IN RULE 144 UNDER THE SECURITIES ACT. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND THE APPLICABLE STATE
SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION THEREUNDER, THE AVAILABILITY OF WHICH IS TO BE ESTABLISHED TO THE
REASONABLE SATISFACTION OF COUNSEL TO THE ISSUER.

 

5.2           Accredited
Investor Status. Such Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D,
as promulgated under the Securities Act.

 

5.3           Reliance
on Exemptions. Such Buyer understands that the Securities are being offered and sold to him, her or it in reliance on specific
exemptions from the registration requirements of United States federal and state securities Laws and that the Company is relying
in part upon the truth and accuracy of, and such Buyer’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility
of such Buyer to acquire the Shares.

 

    	 	6	 

     

    

 

5.4           Information.
Such Buyer and his, her or its advisors, if any, have been furnished with all materials relating
to the business, finances and operations of the Company and other information such Buyer deemed material to making an informed
investment decision regarding his, her or its purchase of the Shares, which have been requested by such Buyer. Such Buyer acknowledges
that he, she or it has received, reviewed and/or had access to a copy of each of the SEC Documents. Among other things, such Buyer
has carefully considered (a) each of the risks described under the heading “Risk Factors” in the Company’s Form
8-K filed November 7, 2016 (SEC Accession No. 0001144204-16-131889) and the other disclosure in that Form 8-K, (b) the additional
risk factors set forth on Exhibit B hereto, (c) the Company’s Form 8-K filed on February 21, 2017 (SEC Accession No. 0001144204-17-010206),
and (d) the other SEC Documents. Such Buyer and his, her or its advisors, if any, have been afforded the opportunity to ask questions
of the Company and its management. Such Buyer understands that his, her or its investment in the Securities involves a high degree
of risk. Such Buyer is in a position regarding the Company, which, based upon employment, family relationship or economic bargaining
power, enabled and enables such Buyer to obtain information from the Company in order to evaluate the merits and risks of his,
her or its investment in the Shares. Such Buyer has sought such accounting, legal and tax advice as he, she or it has considered
necessary to make an informed investment decision with respect to its acquisition of the Securities. Without limiting the foregoing,
such Buyer has carefully considered the potential risks relating to the Company and a purchase of the Securities, and fully understands
that the Securities are a speculative investment that involves a high degree of risk of loss of the Buyer’s entire investment
in the Company. Such Buyer can afford to lose his, her or its entire investment in the Company. 

 

5.5           No
Minimum Offering Amount; Special Risk of Investment. The Company makes no representation or warranty to any Buyer regarding
the aggregate proceeds the Company shall receive in connection with the issuance and sale of Shares pursuant to this Agreement.
There is no minimum Offering size. Each Buyer also understands that the Company may not obtain sufficient funds from this Offering
to implement its current phase of its business plan as set forth in the SEC Documents. Each Buyer understands that the Company
may accept or reject such Buyer’s subscription and purchase of Shares hereunder, at any time, in the Company’s sole
discretion. Additionally, Buyers that subscribe for Shares, whose subscriptions are accepted early in the process of the Offering,
bear a greater risk in respect of their investment because the Company may not raise sufficient funds to implement its business
plan. Buyers who acquire Shares earlier in the Offering process will not receive any additional benefits, payments or other privileges
as a result of such earlier investment. Such Buyer’s Purchase Price, when paid to the Company, will be deposited in the Company’s
bank accounts and will be commingled with the general funds of the Company, subject to the demands of any creditors. Any officer
or director of the Company or the Placement Agent, or any of such parties’ affiliates, may participate in the Offering.

 

5.6           No
Governmental Review. Such Buyer understands that no United States federal or state Governmental Authority has passed on or
made any recommendation or endorsement of the Shares, or the fairness or suitability of an investment in the Securities or the
Company, nor have such Governmental Authorities passed upon or endorsed the merits of the Offering.

 

    	 	7	 

     

    

 

5.7           Authorization,
Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of such Buyer and is a valid
and binding agreement of such Buyer, enforceable in accordance with its terms, except as such enforceability may be limited by
general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws
relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

5.8           General
Solicitation. Such Buyer is not purchasing the Shares as a result of any advertisement, article, notice or other communication
regarding the Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at
any seminar or any other general solicitation or general advertisement. Such Buyer represents that he, she or it had a relationship
with the Placement Agent or the Company preceding its decision to purchase the Shares from the Company.

 

5.9           Residency.
If the Buyer is an individual, then such Buyer resides in the state or province identified on the signature pages hereto as the
address for such Buyer. If the Buyer is a partnership, corporation, limited liability company or other entity, then the office
or offices of such Buyer identified on the signature pages hereto as the address of such Buyer is the location of its principal
place of business and such entity is duly organized in its state of formation.

 

5.10         Brokers
and Finders. Other than the Placement Agent, with respect to such Buyer, no Person will have, as a result of the transactions
contemplated by this Agreement, any valid right, interest or claim against or upon the Company or any Buyer for any commission,
fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of such Buyer. The
Company has agreed to pay a commission to, and reimburse certain expenses of, the Placement Agent in connection with the sale of
the Securities. Such Buyer acknowledges that it is purchasing the Securities directly from the Company and not from the Placement
Agent.

 

5.11         FINRA.
Such Buyer (i) has had no position, office or other material relationship within the past three years with the Company or Persons
known to it to be affiliates of the Company, and (ii) if such Buyer is a member of the Financial Industry Regulatory Authority
(“FINRA”) or an associated person of a member of FINRA, such Buyer, together with its affiliates and any other
associated persons of such member of FINRA, does not, and at the time of the acceptance by the Company of such Buyer’s subscription
for Shares pursuant to this Agreement will not, directly or indirectly have a beneficial interest (as determined under FINRA Rule
5130(i)(1)) of more than 50% of the outstanding voting securities of the Company.

 

    	 	8	 

     

    

 

ARTICLE
VI

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

Except as set forth and
disclosed in the Company’s disclosure schedules (“Disclosure Schedules”) attached to this Agreement and
made a part hereof, the Company and Operating Sub each hereby makes the following representations and warranties to the Buyer and
the Placement Agent. The Disclosure Schedules shall be arranged in sections corresponding to the numbered and lettered sections
and subsections contained in this Article VI and certain other sections of this Agreement, and the disclosures in any section
or subsection of the Disclosure Schedules shall qualify other sections and subsections in this Article VI only to the extent
it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections and subsections.

 

6.1           Subsidiaries.
Except for the Maven Network Inc., a Nevada corporation (the “Operating Sub”), the Company has no subsidiaries
and the Company does not own, directly or indirectly, any outstanding voting securities of or other interests in, or have any control
over, any other Person. The Company wholly-owns the Operating Sub. With respect to the Operating Sub, all representations and warranties
in this Article VI and elsewhere in this Agreement by the Company shall be deemed repeated and re-made from and by the Operating
Sub, as if such representations and warranties were independently made by the Operating Sub, in this Agreement (but modified as
necessary in order to give effect to the intent of the parties that such representation and warranty is being made by the Operating
Sub, rather than the Company, as applicable; provided, however, that in all cases the Company shall remain liable the breach of
any representation and warranty by the Operating Sub). In addition, each representation and warranty contained in this Article
VI or otherwise set forth in this Agreement shall be deemed to mean and be construed to include the Company and each of its
subsidiaries, as applicable, regardless of whether each of such representations and warranties in Article VI specifically
refers to the Company’s subsidiaries or not.

 

6.2           Organization.
The Company, the Operating Sub and their respective subsidiaries are corporations, duly organized, validly existing and in good
standing under the Laws of the jurisdiction in which they are incorporated. The Company has the full corporate power and authority
and all necessary certificates, licenses, approvals and Permits to: (i) enter into and execute this Agreement and the Transaction
Documents and to perform all of its Obligations hereunder and thereunder; and (ii) own and operate its Assets and properties and
to conduct and carry on its business as and to the extent now conducted and currently contemplated to be conducted. The Company
is duly qualified to transact business and is in good standing as a foreign corporation in each jurisdiction where the character
of its business or the ownership or use and operation of its Assets or properties requires such qualification, except to the extent
that failure to so qualify will not result in a Material Adverse Effect.

 

6.3           Authority
and Approval of Agreement; Binding Effect. The execution and delivery by the Company of the Transaction Documents (which includes
this Agreement), and the performance by the Company of all of its Obligations hereunder and thereunder, including the issuance
of the Shares, have been duly and validly authorized and approved by the Company and its board of directors pursuant to all applicable
Laws and no other corporate action or Consent on the part of the Company, its board of directors, its stockholders or any other
Person is necessary or required by the Company to execute and deliver the Transaction Documents, consummate the transactions contemplated
herein and therein, perform all of the Company’s Obligations hereunder and thereunder, or to issue the Shares. Each of the
Transaction Documents have been duly and validly executed by the Company (and the officer executing this Agreement and all such
other Transaction Documents is duly authorized to act and execute same on behalf of the Company) and constitute the valid and legally
binding agreements of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and
other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

    	 	9	 

     

    

 

6.4           Capitalization.
As of February 20, 2017, the authorized capital stock of the Company consists of (i) 100,000,000 shares of Common Stock, of which
22,047,530 shares of Common Stock are issued and outstanding, and (ii) 1,000,000 shares of preferred stock, of which there are
168 shares of the Series G Preferred Stock issued and outstanding. Also, as of February 20, 2017, the Company has issued options
and warrants to purchase 3,098,744 shares of Common Stock. All of such outstanding shares of Common Stock and Series G Preferred
Stock have been validly issued and are fully paid and nonassessable. The Company has received no notice, either oral or written,
with respect to the continued eligibility of the Common Stock for quotation on the Principal Trading Market, and the Company has
maintained all requirements on its part for the continuation of such quotation.  No shares of Common Stock are subject to
preemptive rights or any other similar rights or any Encumbrances suffered or permitted by the Company.  Except as set forth
on Schedule 6.4 of the Disclosure Schedules, as of the date hereof: (i) there are no outstanding options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into,
any shares of capital stock of the Company or any of its subsidiaries, or Contracts, commitments, understandings or arrangements
by which the Company or any of its subsidiaries is or may become bound to issue additional shares of capital stock of the Company
or any of its subsidiaries, or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its subsidiaries; (collectively,
“Derivative Securities”); (ii) there are no outstanding debt securities, notes, credit agreements, credit facilities
or other Contracts or instruments evidencing indebtedness of the Company or any of its subsidiaries, or by which the Company or
any of its subsidiaries is or may become bound; (iii) there are no outstanding registration statements with respect to the
Company or any of its securities (other than registration statements on Form S-8 filed prior to the date hereof); (iv) there
are no agreements or arrangements under which the Company or any of its subsidiaries is obligated to register the sale of any of
their securities under the Securities Act (except pursuant to this Agreement); (v) there are no financing statements securing obligations
filed in connection with the Company or any of its Assets; (vi) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by this Agreement or any related agreement or the consummation of the transactions
described herein or therein; and (vii) there are no outstanding securities or instruments of the Company which contain any redemption
or similar provisions, and there are no Contracts by which the Company is or may become bound to redeem a security of the Company.
Except as set forth on Schedule 6.4 of the Disclosure Schedules, there are no stockholders agreements, voting agreements or other
similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the
Company, between or among any of the Company’s stockholders.

 

    	 	10	 

     

    

 

6.5           No
Conflicts; Consents and Approvals. The execution, delivery and performance of this Agreement and the other Transaction Documents,
and the consummation of the transactions contemplated hereby and thereby, will not: (i) constitute a violation of or conflict with
any provision of the Company’s or any Operating Sub’s certificate or articles of incorporation, bylaws or other organizational
or charter documents; (ii) constitute a violation of, or a default or breach under (either immediately, upon notice, upon lapse
of time, or both), or conflict with, or give to any other Person any rights of termination, amendment, acceleration or cancellation
of, any provision of any Material Contract; (iii) constitute a violation of, or a default or breach under (either immediately,
upon notice, upon lapse of time, or both), or conflict with, any Judgment; (iv) assuming the accuracy of the representations and
warranties of the Buyers set forth in Article V above, constitute a violation of, or conflict with, any Law (including United States
federal and state securities Laws and the rules and regulations of any market or exchange on which the Common Stock is quoted);
or (v) result in the loss or adverse modification of, or the imposition of any fine, penalty or other Encumbrance with respect
to, any Permit granted or issued to, or otherwise held by or for the use of, the Company or any of Company’s Assets. The
Company is not in violation of its certificate of incorporation, bylaws or other organizational or governing documents and the
Company is not in default or breach (and no event has occurred which with notice or lapse of time or both could put the Company
in default or breach) under, and the Company has not taken any action or failed to take any action that would give to any other
Person any rights of termination, amendment, acceleration or cancellation of, any Material Contract. Except as specifically contemplated
by this Agreement, the Company is not required to obtain any Consent of, from, or with any Governmental Authority, or any other
Person, in order for it to execute, deliver or perform any of its Obligations under this Agreement or the Transaction Documents
in accordance with the terms hereof or thereof, or to issue and sell the Shares in accordance with the terms hereof. All Consents
which the Company is required to obtain pursuant to the immediately preceding sentence have been obtained or effected on or prior
to the date hereof.

 

6.6           Issuance
of Securities. The Shares are duly authorized and, upon issuance in accordance with the terms hereof shall be duly issued,
fully paid and non-assessable, and free from all Encumbrances, and, assuming the accuracy of the representations and warranties
of the Buyers set forth in Article V above, will be issued in compliance with all applicable United States federal and state securities
Laws. Assuming the accuracy of the representations and warranties of the Buyers set forth in Article V above, the offer and sale
by the Company of the Shares is exempt from: (i) the registration and prospectus delivery requirements of the Securities Act; and
(ii) the registration and/or qualification provisions of all applicable state and provincial securities and “blue sky”
laws.

 

    	 	11	 

     

    

 

6.7           SEC
Documents; Financial Statements. The Common Stock is registered pursuant to Section 12 of the Exchange Act and the Company
has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the SEC under the
Exchange Act (all of the foregoing filed since November 7, 2016 or amended after the date hereof and all exhibits included therein
and financial statements and schedules thereto and documents incorporated by reference therein, being hereinafter referred to as
the “SEC Documents”). The Company is current with its filing obligations under the Exchange Act and all SEC
Documents have been filed on a timely basis or the Company has received a valid extension of such time of filing and has filed
any such SEC Document prior to the expiration of any such extension. The Company represents and warrants that true and complete
copies of the SEC Documents are available on the SEC’s website (www.sec.gov) at no charge to Buyers, and Buyers acknowledge
that each of them may retrieve all SEC Documents from such website and each Buyer’s access to such SEC Documents through
such website shall constitute delivery of the SEC Documents to Buyers. As of their respective dates, the SEC Documents complied
in all material respects with the requirements of the Exchange Act, and none of the SEC Documents, at the time they were filed
with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
None of the statements made in any such SEC Documents is, or has been, required to be amended or updated under applicable Law (except
as such statements have been amended or updated in subsequent filings prior to the date hereof, which amendments or updates are
also part of the SEC Documents). As of their respective dates, the financial statements of the Company included in the SEC Documents
(“Financial Statements”) complied in all material respects with applicable accounting requirements and the published
rules and regulations of the SEC with respect thereto (except as such Financial Statements have been amended or updated in subsequent
filings prior to the date hereof, which amendments or updates are also part of the SEC Documents). All of the Financial Statements
have been prepared in accordance with GAAP, consistently applied, during the periods involved (except: (i) as may be otherwise
indicated in such Financial Statements or the notes thereto; or (ii) in the case of unaudited interim statements, to the extent
they may exclude footnotes or may be condensed or summary statements), and fairly present in all material respects the consolidated
financial position of the Company as of the dates thereof and the consolidated results of its operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). To the knowledge of the
Company and its officers, no other information provided by or on behalf of the Company to the Buyers which is not included in the
SEC Documents contains any untrue statement of a material fact or omits to state any material fact necessary in order to make the
statements therein, in the light of the circumstance under which they are or were made, not misleading.

 

6.8           Absence
of Certain Changes. Since the date the last of the SEC Documents was filed with the SEC, none of the following have occurred:

 

(a)          There
has been no event or circumstance of any nature whatsoever that has resulted in, or could reasonably be expected to result in,
a Material Adverse Effect; or

 

(b)          Except
for this Agreement and the other Transaction Documents, there has been no transaction, event, action, development, payment, or
other matter of any nature whatsoever entered into by the Company that requires disclosure in an SEC Document which has not been
so disclosed.

 

6.9           Absence
of Litigation or Adverse Matters. Except as disclosed in the SEC Documents: (i) there is no Proceeding before or by any Governmental
Authority or any other Person, pending, or the best of Company’s knowledge, threatened or contemplated by, against or affecting
the Company, its business or Assets; (ii) there is no outstanding Judgments against or affecting the Company, its business or Assets;
and (iii) the Company is not in breach or violation of any Material Contract.

 

6.10         Liabilities
of the Company. The Company does not have any Obligations of a nature required by GAAP to be disclosed on a consolidated balance
sheet of the Company, except: (i) as disclosed in the Financial Statements; or (ii) incurred in the Ordinary Course of Business
since the date of the last Financial Statements filed by the Company with the SEC, or (iii) disclosed on Schedule 6.10 of the Disclosure
Schedules.

 

    	 	12	 

     

    

 

6.11         Title
to Assets. The Company has good and marketable title to, or a valid license or leasehold interest in, all of its Assets which
are material to the business and operations of the Company as presently conducted and as presently contemplated to be conducted,
free and clear of all Encumbrances or restrictions on the transfer or use of same, other than restrictions on transfer or use arising
under a license or Lease with respect to such Assets that, individually or in the aggregate, would not have, or be reasonably expected
to, materially interfere with the purposes for which they are currently used and for the purposes for which they are proposed to
be used. The Company’s Assets are in good operating condition and repair, ordinary wear and tear excepted, and are free of
any latent or patent defects which might impair their usefulness, and are suitable for the purposes for which they are currently
used and for the purposes for which they are proposed to be used.

 

6.12         Real
Estate.

 

(a)          Real
Property Ownership. The Company does not own any Real Property.

 

(b)          Real
Property Leases. Except pursuant to the Leases described in the SEC Documents (the “Company Leases”), the
Company does not lease any Real Property. With respect to each of the Company Leases, except as disclosed in the SEC Documents,
(i) the Company has been in peaceful possession of the property leased thereunder and neither the Company nor, to the Company’s
knowledge, the landlord is in default thereunder; (ii) no waiver, indulgence or postponement of any of the Obligations thereunder
has been granted by the Company or landlord thereunder; and (iii) there exists no event, occurrence, condition or act known to
the Company which, upon notice or lapse of time or both, would be or could become a default thereunder or which could result in
the termination of the Company Leases, or any of them, or have a Material Adverse Effect on the business of the Company, its Assets
or its operations or financial results. The Company has not violated nor breached any provision of any such Company Leases, and
all Obligations required to be performed by the Company under any of such Company Leases have been fully, timely and properly performed.
If requested by any of the Buyers, the Company has delivered to such Buyers true, correct and complete copies of all Company Leases,
including all modifications and amendments thereto, whether in writing or otherwise. The Company has not received any written or
oral notice to the effect that any of the Company Leases will not be renewed at the termination of the term of such Company Leases,
or that any of such Company Leases will be renewed only at higher rents.

 

6.13         Material
Contracts. An accurate, current and complete copy of each of the Material Contracts is readily available and filed with the
SEC as part of the SEC Documents, and each of the Material Contracts constitutes the principal terms of the agreement of the respective
parties thereto relating to the subject matter thereof. Each of the Material Contracts is in full force and effect and is a valid
and binding Obligation of the parties thereto in accordance with the terms and conditions thereof. The Obligation required to be
performed by the Company under each of the Material Contracts have been fully performed in all material respects and the Company
is not in default under any of the Material Contracts and, to the knowledge of the Company and its officers, all Obligations required
to be performed under the terms of each of the Material Contracts by any party thereto other than the Company have been fully performed
by all parties thereto, and no party to any Material Contracts is in default with respect to any term or condition thereof, nor
has any event occurred which, through the passage of time or the giving of notice, or both, would constitute a default thereunder
or would cause the acceleration or modification of any Obligation of any party thereto or the creation of any Encumbrance upon
any of the Assets of the Company. Further, the Company has received no notice, nor does the Company have any knowledge, of any
pending or contemplated termination of any of the Material Contracts and, no such termination is proposed or has been threatened,
whether in writing or orally.

 

    	 	13	 

     

    

 

6.14         Compliance
with Laws. Except as set forth on Schedule 6.14 of the Disclosure Schedules, the Company is and at all times has been in material
compliance with all Laws. The Company has not received any notice that it is in violation of, has violated, or is under investigation
with respect to, or has been threatened to be charged with, any violation of any Law.

 

6.15         Intellectual
Property. The Company owns or possesses adequate and legally enforceable rights or licenses to use all trademarks, trade names,
service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and all other intellectual property rights necessary to conduct its business as now
conducted and as currently contemplated to be conducted. The Company has not infringed trademarks, trade name rights, patents,
patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, trade secrets or other
intellectual property rights of others, and there is no Claim being made or brought against, or to the Company’s knowledge,
being threatened against, the Company regarding trademarks, trade names, patents, patent rights, inventions, copyrights, licenses,
service names, service marks, service mark registrations, trade secrets or other intellectual property infringement; and the Company
is unaware of any facts or circumstances which might give rise to any of the foregoing.

 

6.16         Labor
and Employment Matters. The Company is not involved in any labor dispute or, to the knowledge of the Company, is any such dispute
threatened. To the knowledge of the Company and its officers, none of the Company’s employees is a member of a union and
the Company believes that its relations with its employees are good. To the knowledge of the Company and its officers, the Company
has complied in all material respects with all Laws relating to employment matters, civil rights and equal employment opportunities.

 

6.17         Employee
Benefit Plans. The Company is in compliance in all material respects with all presently applicable provisions of the Employee
Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations thereunder (“ERISA”);
no “reportable event” (as defined in ERISA) has occurred with respect to any “pension plan” (as defined
in ERISA) for which the Company would have any Obligation; the Company has not incurred and does not expect to incur any Obligation
under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any “pension plan” or (ii) Sections
412 or 4971 of the Internal Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder
(the “Code”); and each “pension plan” for which the Company would have any liability that is intended
to be qualified under Section 401(a) of the Code is so qualified in all material respects and nothing has occurred, whether by
action or by failure to act, which would cause the loss of such qualification. To the Company’s knowledge, the Company has
promptly paid and discharged all Obligations arising under ERISA of a character which if unpaid or unperformed might result in
the imposition of an Encumbrance against any of its Assets or otherwise have a Material Adverse Effect.

 

    	 	14	 

     

    

 

6.18         Tax
Matters. The Company has timely filed all Tax Returns required by any jurisdiction to which it is subject, and each such Tax
Return has been prepared in compliance with all applicable Laws, and all such Tax Returns are true and accurate in all respects.
Except and only to the extent that the Company has set aside on its books provisions reasonably adequate for the payment of all
unpaid and unreported Taxes in compliance with Law, the Company has timely paid all Taxes shown or determined to be due on such
Tax Returns, except those being contested in good faith, and the Company has set aside on its books provision reasonably adequate
for the payment of all Taxes for periods subsequent to the periods to which such Tax Returns apply. There are no unpaid Taxes in
any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis
for any such claim. The Company has withheld and paid all Taxes to the appropriate Governmental Authority required to have been
withheld and paid in connection with amounts paid or owing to any Person. There is no Proceeding or Claim for a
refund now in progress, pending or, to the Company’s knowledge, threatened against or with respect to the Company regarding
Taxes.

 

6.19         Insurance.
The Company is covered by valid, outstanding and enforceable policies of insurance which were issued to it by reputable insurers
of recognized financial responsibility, covering its properties, Assets and businesses against losses and risks normally insured
against by other corporations or entities in the same or similar lines of businesses as the Company is engaged and in coverage
amounts which are prudent and typically and reasonably carried by such other corporations or entities (the “Insurance
Policies”). Such Insurance Policies are in full force and effect, and all premiums due thereon have been paid. None of
the Insurance Policies will lapse or terminate as a result of the transactions contemplated by this Agreement. The Company has
complied with the provisions of such Insurance Policies. The Company has not been refused any insurance coverage sought or applied
for and the Company does not have any reason to believe that it will not be able to renew its existing Insurance Policies as and
when such Insurance Policies expire or to obtain similar coverage from similar insurers as may be necessary to continue its business
at a cost that would not materially and adversely affect the condition, financial or otherwise, or the earnings, business or operations
of the Company. There is no material claim pending under any Insurance Policies as to which coverage has been questioned, denied
or disputed by the underwriters of such Insurance Policies.

 

6.20         Permits.
The Company possesses all Permits necessary to conduct its business, and the Company has not received any notice of, and is not
otherwise involved in any Proceedings relating to, the revocation or modification of any such Permits. All such Permits are valid
and in full force and effect and the Company is in material compliance with the respective requirements of all such Permits.

 

6.21         Business
Location. The Company has no office or place of business other than as identified in the SEC Documents and the Company’s
principal executive offices are located in Seattle, Washington. All books and records of the Company and other material Assets
of the Company are held or located at the offices and places of business identified in the SEC Documents.

 

    	 	15	 

     

    

 

6.22         Environmental
Laws. The Company is and has at all times been in compliance in all material respects with any and all applicable Environmental
Requirements, and there are no pending Claims against the Company relating to any Environmental Requirements, nor to the best knowledge
of the Company, is there any basis for any such Claims.

 

6.23         Illegal
Payments. Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company has,
in the course of his actions for, or on behalf of, the Company: (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of
the U.S. Foreign Corrupt Practices Act of 1977, as amended (or similar anticorruption or antibribery laws of other jurisdictions);
or (iv) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government
official or employee.

 

6.24         Related
Party Transactions. Except as disclosed in the SEC Documents, and except for arm’s length transactions pursuant to which
the Company makes payments in the Ordinary Course of Business upon terms no less favorable than the Company could obtain from unaffiliated
third parties, none of the officers, directors or employees of the Company, nor any stockholders who own, legally or beneficially,
five percent (5%) or more of the issued and outstanding shares of any class of the Company’s capital stock (each a “Material
Shareholder”), is presently a party to any transaction with the Company (other than for services as employees, officers
and directors), including any Contract providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from, any officer, director or such employee or Material Shareholder
or, to the best knowledge of the Company, any other Person in which any officer, director, or any such employee or Material Shareholder
has a substantial or material interest in or of which any officer, director or employee of the Company or Material Shareholder
is an officer, director, trustee or partner. There are no Claims or disputes of any nature or kind between the Company,
on the one hand, and any officer, director or employee of the Company or any Material Shareholder, on the other hand,
or, to the Company’s knowledge, between or among any of them, relating to the Company and its business.

 

6.25         Internal
Accounting Controls. Except as set forth in the SEC Documents, the Company and each of its subsidiaries maintain a system of
internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to Assets is permitted
only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for Assets
is compared with the existing Assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

    	 	16	 

     

    

 

6.26         Acknowledgment
Regarding Buyers’ Purchase of the Shares. The Company acknowledges and agrees that each Buyer is acting solely in the
capacity of an arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby. The Company
further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to this Agreement and the transactions contemplated hereby and any advice given by any Buyer or any of its representatives
or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental to such Buyer’s
purchase of the Shares. The Company further represents to each Buyer that the Company’s decision to enter into this Agreement
has been based solely on the independent evaluation by the Company and its representatives.

 

6.27         Listing
and Maintenance Requirements. The Company’s Common Stock is registered pursuant to Section 12 of the Exchange Act, and
the Company has taken no action designed to, or which to the best of its knowledge is likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act, nor has the Company received any notification that the SEC is contemplating
terminating such registration.

 

6.28         Bad
Actor. No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification
Event”) is applicable to the Company or, to the Company’s knowledge, any Company Covered Person. As used in this
Section 6.28, the term “Company Covered Person” means, with respect to the Company as an “issuer”
for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

 

6.29         Brokerage
Fees. Except for the Placement Agent, there is no Person acting on behalf of the Company who is entitled to or has any claim
for any financial advisory, brokerage or finder’s fee or commission in connection with the execution of this Agreement or
the consummation of the transactions contemplated hereby. Pursuant to the Engagement Letter, the Company has agreed to pay the
Placement Agent (A) a cash fee equal to 5% and shares of Common Stock of the Company equal to 5% of the gross proceeds received
by the Company (with the number of shares of Common Stock to be determined based on the lowest price per share paid by the investors
in the Offering) in respect of Buyers introduced by the Placement Agent to the Company (“MDB Buyers”), and (B)
a cash fee of 5% of the gross proceeds received by the Company in respect of Buyers who are not MDB Buyers. The foregoing fees
and shares of Common Stock are to be paid to the Placement Agent from time to time as the subscriptions from Buyers are accepted
by the Company, and the share portion of the fee is subject to increase if the Company issues additional shares to Buyers pursuant
to Section 7.7 hereof. The Company has also agreed to reimburse the Placement Agent up to $32,500 for its expenses and its legal
fees and expenses in connection with the sale of the Shares.

 

6.30         Disclosure.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company
confirms that, to the knowledge of the Company, neither it nor any other Person acting on its behalf has provided any of the Buyers
or their agents or counsel with any information that it believes constitutes or might constitute material, nonpublic information.
The Company understands and confirms that each of the Buyers will rely on the foregoing representation in effecting the contemplated
transaction in securities of the Company under this Agreement.

 

    	 	17	 

     

    

 

6.31         No
Integrated Offering. Neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security under circumstances that would
cause the Offering to be integrated with prior offerings by the Company for purposes of the Securities Act which would require
the registration of any such Securities under the Securities Act.

 

6.32         No
Investment Company. The Company is not, and is not an affiliate of, and immediately after receipt of payment for the Securities
will not be, or be an affiliate of, an “investment company,” a company controlled by an “investment company”
or an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.

 

6.33         U.S.
Real Property Holding Corporation. The Company is not, nor has ever been, and so long as any of the Securities are held by
any of the Buyers, shall not become, a U.S. real property holding corporation within the meaning of Section 897 of the Code, and
the Company shall so certify upon any Buyer’s request.

 

ARTICLE
VII

COVENANTS

 

7.1           Best
Efforts. Each party shall use its best efforts to timely satisfy each of the conditions to be satisfied by it as provided in
Articles VIII and IX of this Agreement.

 

7.2           Form
D. If required by applicable Law, the Company agrees to file a Form D with respect to the sale of the Shares as required under
Regulation D of the Securities Act and to provide a copy thereof to the Placement Agent. The Company shall take such action as
the Company shall reasonably determine is necessary to qualify the Shares, or obtain an exemption for the Shares for sale to each
of the Buyers pursuant to this Agreement under applicable securities or “Blue Sky” Laws of the states of the United
States, and shall provide evidence of any such action so taken to the Placement Agent.

 

7.3           Affirmative
Covenants.

 

(a)          Reporting
Status; Listing. Until the earlier of two (2) years from the date hereof or when the Shares are no longer registered in the
names of the Buyers on the books and records of the Company, the Company shall: (i) file in a timely manner all reports required
to be filed under the Securities Act, the Exchange Act or any securities Laws and regulations thereof applicable to the Company
of any state of the United States, or by the rules and regulations of the Principal Trading Market, and, if not otherwise publicly
available, to provide a copy thereof to each Buyer upon request; (ii) not terminate its status as an issuer required to file
reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would otherwise permit such termination;
(iii) if required by the rules and regulations of the Principal Trading Market, promptly secure the listing of any of the Shares
upon the Principal Trading Market (subject to official notice of issuance) and, take all reasonable action under its control to
maintain the continued listing, quotation and trading of its Common Stock on the Principal Trading Market, and the Company shall
comply in all respects with the Company’s reporting, filing and other Obligations under the bylaws or rules of the Principal
Trading Market, the Financial Industry Regulatory Authority, Inc. and such other Governmental Authorities, as applicable.

 

    	 	18	 

     

    

 

(b)          Rule
144. With a view to making available to each Buyer the benefits of Rule 144 under the Securities Act (“Rule 144”),
or any similar rule or regulation of the SEC that may at any time permit Buyers to sell the Shares to the public without registration,
the Company represents and warrants to the Buyers and the Placement Agent that the Company ceased being a Shell Company on November
7, 2016, and since that date has been subject to Section 13 or 15(d) of the Exchange Act and has filed all required reports thereunder.
For the purposes hereof, the term “Shell Company” shall mean an issuer that meets the description set forth
under Rule 144(i)(1)(i). In addition, until the earlier of three (3) years from the date hereof or when the Shares no longer are
required to bear a restrictive legend, the Company shall, at its sole expense:

 

(i)          make,
keep and ensure that adequate current public information with respect to the Company, as required in accordance with Rule 144,
is publicly available;

 

(ii)         furnish
to each Buyer, promptly upon reasonable request: (A) a written statement, executed by a senior officer of the Company, certifying
that the Company has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange Act; and (B) such
other information as may be reasonably requested by each Buyer to permit each Buyer to sell any of the Shares pursuant to Rule
144 without limitation or restriction; and

 

(iii)        promptly
at the request of each Buyer at any time on or after November 7, 2017, give the Company’s transfer agent instructions to
the effect that, upon the transfer agent’s receipt from any Buyer of a certificate (a “Rule 144 Certificate”)
certifying that such Buyer’s holding period (as determined in accordance with the provisions of Rule 144) for any portion
of the Shares which such Buyer proposes to sell (the “Securities Being Sold”) is not less than six (6) months,
and receipt by the transfer agent of the “Rule 144 Opinion” (as hereinafter defined) from the Company or its counsel
(or from such Buyer and its counsel as permitted below), the transfer agent is to effect the transfer of the Securities Being Sold
and issue to such Buyer or transferee(s) thereof one or more stock certificates representing the transferred Securities Being Sold
without any restrictive legend and without recording any restrictions on the transferability of such Securities Being Sold on the
transfer agent’s books and records or, at the Buyer’s option, the Securities Being Sold shall be transmitted by the
transfer agent to the Buyer by crediting the account of the Buyer’s or its designee’s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system if the transfer agent is then a participant in such system.
In this regard, upon each Buyer’s request, the Company shall have an affirmative obligation at its expense to cause its counsel
to promptly issue to the transfer agent a legal opinion providing that, based on the Rule 144 Certificate, the Securities Being
Sold were or may be sold, as applicable, pursuant to the provisions of Rule 144, even in the absence of an effective registration
statement (the “Rule 144 Opinion”). If the transfer agent requires any additional documentation in connection
with any proposed transfer by any Buyer of any Securities Being Sold, the Company shall promptly deliver or cause to be delivered
to the transfer agent or to any other Person, all such additional documentation as may be necessary to effectuate the transfer
of the Securities Being Sold and the issuance of an unlegended certificate to any transferee thereof, all at the Company’s
expense.

 

    	 	19	 

     

    

 

7.4           Use
of Proceeds. The Company shall use the net proceeds from the sale of the Shares for working capital and general corporate purposes,
including marketing and product promotion, capital expenditures and payment of the fees and expenses incurred in connection with
the Offering.

 

7.5           Fees
and Expenses. The Company agrees to pay to each Buyer (or any designee or agent of the Buyers), upon demand, or to otherwise
be responsible for the payment of, any and all costs, fees, charges and expenses, including the reasonable fees, costs, expenses
and disbursements of counsel for any Buyer, and of any experts and agents, which any Buyer may incur or which may otherwise be
due and payable in connection with any documentary stamp taxes, intangibles taxes, recording fees, filing fees, or other similar
taxes, fees or charges imposed by or due to any Governmental Authority in connection with this Agreement or any other Transaction
Documents; The provisions of this Subsection shall survive the termination of this Agreement.

 

7.6           Public
Disclosure of Buyers. The Company shall not publicly disclose the name of any Buyer, or include the name of any Buyer in any
filing with the SEC or any regulatory agency or Principal Trading Market, without the prior written consent of such Buyer except:
(a) as required by federal securities law in connection with any registration statement contemplated by the Registration Rights
Agreement or (b) to the extent such disclosure is required by Law or Principal Trading Market regulations, in which case the Company
shall provide Buyers with prior written notice of such disclosure permitted under this clause (b).

 

7.7           Additional
Shares. In the event the Company issues any Shares pursuant to this Agreement and the price per Share (the “New Purchase
Price”) paid by Buyers purchasing such Shares (the “Subsequent Buyers”) is less than the Purchase
Price, the Company shall issue to each Buyer (each, a “Specified Buyer” and, together, the “Specified
Buyers”) who had purchased Shares prior to the purchase of Shares by the Subsequent Buyer, for no additional consideration
whatsoever, a number of additional Shares equal to (A) (x) the number of Shares previously purchased by such Specified Buyer multiplied
by (y) (I) the Purchase Price minus (II) the New Purchase Price divided by (B) the New Purchase Price. In the event any of the
Specified Buyers entitled to receive additional Shares pursuant to this Section 7.8 is an MDB Investor, the Company shall, simultaneously
with the issuance of such Shares to the Specified Buyers, issue to the Placement Agent, for no additional consideration and pursuant
to the terms of the Engagement Letter, a number of additional Shares equal to (A) the aggregate number of additional Shares to
be issued to such MDB Investor, multiplied by (B) 5.0%, rounded down to the nearest whole Share.

 

ARTICLE
VIII

CONDITIONS PRECEDENT TO THE COMPANY’S
OBLIGATIONS TO SELL

 

The obligation of the Company
hereunder to issue and sell the Shares to each Buyer is subject to the satisfaction, at or before the acceptance of a subscription
by the Company from such Buyer, of each of the following conditions, provided that these conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion:

 

    	 	20	 

     

    

 

8.1           The
Buyer acquiring Shares shall have executed the Transaction Documents that require the Buyer’s execution, and delivered them
to the Company.

 

8.2           The
Buyer acquiring Shares shall have paid the Buyer’s Purchase Price to the Company.

 

8.3           The
representations and warranties of the Buyer acquiring Shares shall be true and correct in all material respects as of the date
when made and as of the acceptance by the Company of such Buyer’s subscription as though made at that time (except for representations
and warranties that speak as of a specific date, which shall be true and correct as of such specific date), and such Buyer shall
have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by such Buyer at or prior to the acceptance of such Buyer’s subscription
for Shares by the Company.

 

8.4           The
Company shall have obtained all governmental, regulatory or third party consents and approvals necessary for the sale of the Shares.

 

8.5           No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or Governmental Authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.

 

8.6           Since
the date of execution of this Agreement, no event or series of events shall have occurred that resulted, or could reasonably be
expected to result, in a Material Adverse Effect.

 

8.7           Trading
in the Common Stock shall not have been suspended by the SEC or any Principal Trading Market at any time since the date of execution
of this Agreement.

 

ARTICLE
IX

CONDITIONS PRECEDENT TO
A BUYER’S OBLIGATIONS TO PURCHASE

 

The obligation of a Buyer
hereunder to purchase the Shares is subject to the satisfaction, at or before the acceptance by the Company of such Buyer’s
subscription for Shares, of each of the following conditions (in addition to any other conditions precedent elsewhere in this Agreement),
provided that these conditions are for the benefit of each Buyer acquiring Shares and may be waived by each such Buyer at any time
in their sole discretion:

 

9.1           The
Company shall have executed and delivered the Transaction Documents and delivered the same to the Placement Agent and the Buyers.

 

9.2           The
Company shall have delivered to the transfer agent for the Company’s Common Stock issuance instructions and all other documents
required by such transfer agent to issue by direct registration in book-entry form in such Buyer’s name the number of Shares
that the Buyer is purchasing.

 

    	 	21	 

     

    

 

9.3           The
representations and warranties of the Company and the Operating Sub shall be true and correct in all material respects (except
to the extent that any of such representations and warranties are already qualified as to materiality, Material Adverse Effect
or similar qualification in Article VI above, in which case, such representations and warranties shall be true and correct in all
respects without further qualification) as of the date when made and as of the Company’s acceptance of such Buyer’s
subscription for Shares as though made at that time (except for representations and warranties that speak as of a specific date,
which shall be true and correct as of such specific date) and the Company and the Operating Sub shall have performed, satisfied
and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed,
satisfied or complied with by the Company and the Operating Sub at or prior to acceptance of such subscription.

 

9.4           The
Company shall have obtained all governmental, regulatory or third party consents and approvals necessary for the sale of the Shares.

 

9.5           No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or Governmental Authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.

 

9.6           Trading
in the Common Stock shall not have been suspended by the SEC or any Principal Trading Market at any time since the date of execution
of this Agreement.

 

9.7           Since
the date of execution of this Agreement, no event or series of events shall have occurred that resulted, or could reasonably be
expected to result, in a Material Adverse Effect.

 

ARTICLE
X

INDEMNIFICATION

 

10.1         Company’s
Obligation to Indemnify. In consideration of the Placement Agent’s and each Buyers’ execution and delivery of this
Agreement, and in addition to all of the Company’s other obligations under this Agreement, the Company hereby agrees to defend
and indemnify the Placement Agent, each Buyer, and each Affiliates of the Placement Agent and each Buyer and their respective subsidiaries,
and their respective directors, officers, employees, agents and representatives, and the successors and assigns of each of them
(collectively, the “Buyer Indemnified Parties”) and the Company hereby agrees to hold the Buyer Indemnified
Parties harmless, from and against any and all Claims made, brought or asserted against the Buyer Indemnified Parties, or any one
of them, and the Company hereby agrees to pay or reimburse the Buyer Indemnified Parties for any and all Claims payable by any
of the Buyer Indemnified Parties to any Person, including reasonable attorneys’ and paralegals’ fees and expenses,
court costs, settlement amounts, costs of investigation and interest thereon from the time such amounts are due at one-half of
the highest non-usurious rate of interest permitted by applicable Law in the state of New York, through all negotiations, mediations,
arbitrations, trial and appellate levels, as a result of, or arising out of, or relating to: (i) any misrepresentation or breach
of any representation or warranty made by the Company or any Operating Subs in this Agreement, the other Transaction Documents
or any other certificate, instrument or document contemplated hereby or thereby; (ii) any breach of any covenant, agreement or
Obligation of the Company or any Operating Sub contained in this Agreement, the other Transaction Documents or any other certificate,
instrument or document contemplated hereby or thereby; or (iii) any Claims brought or made against the Buyer Indemnified Parties,
or any one of them, by any Person and arising out of or resulting from the execution, delivery, performance or enforcement of this
Agreement, the other Transaction Documents or any other instrument, document or agreement executed pursuant hereto or thereto.
To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum
contribution to the payment and satisfaction of each of the Claims covered hereby, which is permissible under applicable Law. The
Company will not be liable to any Buyer under this Section 10.1: (i) for any settlement by a Buyer in connection with any Claim
effected without the Company’s prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed;
or (ii) to the extent, but only to the extent, that a Claim is attributable solely to any Buyer’s breach of any of the representations,
warranties, covenants or agreements made by such Buyer in this Agreement or in the other Transaction Documents.

 

    	 	22	 

     

    

 

ARTICLE
XI

MATTERS RELATING TO THE BUYERS

 

11.1         Independent
Nature of Buyers’ Obligations and Rights. The obligations of each Buyer under this Agreement and the Transaction Documents
are several and not joint with the obligations of any other Buyer or the Placement Agent, and neither the Placement Agent nor any
Buyer shall be responsible in any way for the performance of the obligations of any other Buyer under any one or more of the Transaction
Documents. The decision of each Buyer to purchase the Shares pursuant to the Transaction Documents has been made by each such Buyer
independently of the Placement Agent and the other Buyers and independently of any information, materials, statements or opinions
as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition (financial or otherwise)
of the Company or of its subsidiaries, if any, which may have been made or given by the Placement Agent and any other Buyer or
any of their respective officers, directors, principals, employees, agents, counsel or representatives (collectively, including
the Placement Agent and the Buyer in question, the “Buyer Representatives”). No Buyer Representative shall have any
liability to any other Buyer or the Company relating to or arising from any such information, materials, statements or opinions,
if any. Each Buyer acknowledges that neither the Placement Agent nor any other Buyer has acted as agent for such Buyer in connection
with making its investment decision hereunder and that neither the Placement Agent nor any Buyer will be acting as agent of such
other Buyer in connection with monitoring such Buyer’s investment in the Securities or enforcing its rights under the Transaction
Documents. Each Buyer shall be entitled to independently protect and enforce its rights, including, without limitation, the rights
arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Buyer to be
joined as an additional party in any Proceeding for such purpose. The Company and each of the Buyers acknowledge that, for reasons
of administrative convenience the Company has elected to provide each of the Buyers with the same Transaction Documents for the
purpose of closing a transaction with multiple Buyers and not because it was required or requested to do so by any Buyer. In furtherance
of the foregoing, and not in limitation thereof, the Company and the Buyers acknowledge that nothing contained in this Agreement
or in any Transaction Document, and no action taken by any Buyer pursuant thereto, shall be deemed to constitute any two or more
Buyers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Buyers are
in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction
Documents. Each Buyer acknowledges that he ,she or it has been advised by his or her own legal counsel, or has had the opportunity
to engage his, her or its own legal counsel, with respect to this Agreement, the other Transaction Documents, and the transactions
contemplated hereby and thereby and each Buyer understands and agrees that (i) he, she or it has carefully read and fully understands
all of the terms of this Agreement and each Transaction Document to which he, she or it is a party; and (ii) he or she is under
no disability or impairment that affects his or her decision to sign this Agreement or the other Transaction Documents and he or
she knowingly and voluntarily intends to be legally bound by this Agreement and the Transaction Documents.

 

    	 	23	 

     

    

 

11.2         Equal
Treatment of Buyers. No consideration shall be offered or paid to any Buyer to amend or consent to a waiver or modification
of any provision of this Agreement or any of the other Transaction Documents, unless the same consideration is also offered to
all of the other Buyers parties to the Transaction Documents.

 

ARTICLE
XII

TERMINATION

 

12.1         Termination.
This Agreement may be terminated prior to Outside Closing Date (defined below) (i) by written agreement of the Placement Agent,
any Buyer who had signed this Agreement but who had not yet acquired Shares and the Company, or (ii) by either the Company or a
Buyer who had signed this Agreement but not yet acquired Shares (as to itself but no other Buyer) upon written notice to the other,
if the acceptance by the Company of a subscription shall not have taken place by March 20, 2017, or such later date approved by
the Company’s Board of Directors and the Placement Agent, but in no event later than March 28, 2017 (“Outside Closing
Date”); provided, that the right to terminate this Agreement under this Section 12.1 shall not be available to
any party whose failure to comply with its obligations under this Agreement has been the cause of or resulted in the failure of
the issuance and sale of Shares to occur on or before such time.

 

12.2         Consequences
of Termination. No termination of this Agreement shall release any party from any liability for breach by such party of the
terms and provisions of this Agreement or the other Transaction Documents.

 

    	 	24	 

     

    

 

ARTICLE
XIII

MISCELLANEOUS

 

13.1         Notices.
All notices of request, demand and other communications hereunder shall be addressed to the parties as follows:

 

	If to the Company:	theMaven, Inc.
	 	5048 Roosevelt Way NE
	 	Seattle, WA
	 	Attention: Bill Sornsin
	 	Email: billso@themaven.net
	 	 
	With a copy (which shall not constitute notice pursuant to this Section 13.1) to:
	 	 
	 	Golenbock Eiseman Assor Bell & Peskoe LLP
	 	711 Third Avenue
	 	New York, New York  10017
	 	Attention:  Andrew D. Hudders
	 	Email: ahudders@golenbock.com
	 	Facsimile: (212) 818-8881
	 	 
	If to the Placement Agent:	MDB Capital Group, LLC
	 	2425 Cedar Springs Road
	 	Dallas, Texas 75201
	 	Attention: Christopher A. Marlett
	 	Email: d@mdb.com
	 	Facsimile: (310) 526-5020
	 	 
	With a copy (which shall not constitute notice pursuant to this Section 13.1) to:
	 	 
	 	Sheppard, Mullin Richter & Hampton LLP
	 	379 Lytton Avenue
	 	Palo Alto, California 94301
	 	Attention:  Jason R. Schendel
	 	Email: jschendel@sheppardmullin.com
	 	 
	If to the Buyers:	To each Buyer based on the information set forth in the Schedule of Buyers attached hereto

 

unless the address is changed by the party
by like notice given to the other parties. Notice shall be in writing and shall be deemed delivered: (i) if mailed by certified
mail, return receipt requested, postage prepaid and properly addressed to the address above, then three (3) business days after
deposit of same in a regularly maintained U.S. mail receptacle; or (ii) if mailed by Federal Express, UPS or other nationally recognized
overnight courier service, next business morning delivery, then one (1) business day after deposit of same in a regularly maintained
receptacle of such overnight courier; or (iii) if hand delivered, then upon hand delivery thereof to the address indicated on or
prior to 5:00 p.m., New York time, on a business day. Any notice hand delivered after 5:00 p.m., New York time, shall be deemed
delivered on the following business day. Notwithstanding the foregoing, notice, consents, waivers or other communications referred
to in this Agreement may be sent by facsimile, e-mail, or other method of delivery, but shall be deemed to have been delivered
only when the sending party has confirmed (by reply e-mail or some other form of written confirmation from the receiving party)
that the notice has been received by the other party.

 

    	 	25	 

     

    

 

13.2         Entire
Agreement. This Agreement, including the Exhibits and Schedules attached hereto and the documents delivered pursuant hereto,
including the Transaction Documents other than this Agreement, and the Engagement Letter, set forth all the promises, covenants,
agreements, conditions and understandings between the parties hereto with respect to the subject matter hereof and thereof, and
supersede all prior and contemporaneous agreements, understandings, inducements or conditions, expressed or implied, oral or written,
except as contained herein and in the Transaction Documents; provided, however, except as explicitly stated herein, nothing contained
in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements any Buyer
has entered into with, or any instruments any Buyer has received from, the Company prior to the date hereof with respect to any
prior investment made by such Buyer in the Company or (ii) waive, alter, modify or amend in any respect any obligations of the
Company, or any rights of or benefits to any Buyer or any other Person, in any agreement entered into prior to the date hereof
between or among the Company and any Buyer, or any instruments any Buyer received from the Company prior to the date hereof, and
all such agreements and instruments shall continue in full force and effect in accordance with their respective terms. In addition,
as between the Placement Agent and the Company, in the event of any conflict between the terms of the Engagement Letter and the
terms of this Agreement, the terms of the Engagement Letter shall govern.

 

13.3         Successors
and Assigns. This Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned, transferred,
delegated or sublicensed by the Company without the prior written consent of the Placement Agent and each Buyer. Subject to the
foregoing and except as otherwise provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding
upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 

13.4         Binding
Effect. This Agreement shall be binding upon the parties hereto, their respective successors and permitted assigns.

 

    	 	26	 

     

    

 

13.5         Amendment.
Except as specifically set forth herein, neither the Company nor any Buyer makes any representation, warranty, covenant or undertaking
with respect to such matters. For clarification purposes, the Recitals are part of this Agreement. No provision of this Agreement
may be amended other than by an instrument in writing signed by the Company, the Placement Agent and the Required Buyers. Any amendment
to any provision of this Agreement made in conformity with the provisions of this Section 13.5 shall be binding on all Buyers and
holders of Securities, as applicable, provided that no such amendment shall be effective to the extent that it (1) applies to less
than all of the holders of the Securities then outstanding, (2) imposes any Obligation or liability on any Buyer without such Buyer’s
prior written consent (which may be granted or withheld in such Buyer’s sole discretion), or (3) adversely affects any Buyer
in a manner differently than other Buyers. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party, provided that the Required Buyers may waive any provision of this Agreement, and any waiver of any provision
of this Agreement made in conformity with the provisions of this Section 13.5 shall be binding on all Buyers and holders of Securities,
as applicable, provided that no such waiver shall be effective to the extent that it (1) applies to less than all of the holders
of the Securities then outstanding (unless a party gives a waiver as to itself only), (2) imposes any Obligation on any Buyer without
such Buyer’s prior written consent (which may be granted or withheld in such Buyer’s sole discretion)., or (3) adversely
affects any Buyer in a manner differently than other Buyers. No consideration shall be offered or paid to any Person to amend or
consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration also is
offered to all of the parties to the Transaction Documents who are holders of Securities. The Company has not, directly or indirectly,
made any agreements with any Buyers relating to the terms or conditions of the transactions contemplated by the Transaction Documents
except as set forth in the Transaction Documents. Without limiting the foregoing, the Company confirms that, except as set forth
in this Agreement, no Buyer has made any commitment or promise or has any other Obligation to provide any financing to the Company
or otherwise. As a material inducement for each Buyer to enter into this Agreement, the Company expressly acknowledges and agrees
that no due diligence or other investigation or inquiry conducted by a Buyer or any Buyer Representative shall affect such Buyer’s
right to rely on, or shall modify or qualify in any manner or be an exception to any of, the Company’s representations and
warranties contained in this Agreement or any other Transaction Document. “Required Buyers” means, as of any
date of determination, Buyers holding a majority of the Shares sold pursuant to this Agreement.

 

13.6         Gender
and Use of Singular and Plural. All pronouns shall be deemed to refer to the masculine, feminine, neuter, singular or plural,
as the identity of the party or parties or their personal representatives, successors and assigns may require.

 

13.7         Execution.
This Agreement may be executed in one or more counterparts, all of which taken together shall be deemed and considered one and
the same Agreement, and same shall become effective when counterparts have been signed by each party and each party has delivered
its signed counterpart to the other party. A digital reproduction, portable document format (“.pdf”) or other reproduction
of this Agreement may be executed by one or more parties hereto and delivered by such party by electronic signature (including
signature via DocuSign or similar services), electronic mail or any similar electronic transmission device pursuant to which
the signature of or on behalf of such party can be seen. Such execution and delivery shall be considered valid, binding and effective
for all purposes.

 

13.8         Headings.
The article and section headings contained in this Agreement are inserted for convenience only and shall not affect in any way
the meaning or interpretation of the Agreement.

 

    	 	27	 

     

    

 

13.9         Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in
the state and federal courts sitting in the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the State of New York, for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert
in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Each party
hereby irrevocably waives any right it may have, and agrees not to request, a jury trial for the adjudication of any dispute hereunder
or in connection with or arising out of this Agreement or any transaction contemplated hereby. If either party shall commence an
action or proceeding to enforce any provisions of the Transaction Documents, then the prevailing party in such action or proceeding
shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such action or proceeding.

 

13.10         Further
Assurances. The parties hereto will execute and deliver such further instruments and do such further acts and things as may
be reasonably required to carry out the intent and purposes of this Agreement.

 

13.11         Survival.
The representations and warranties contained herein shall survive the expiration or termination of this Agreement. Each Buyer shall
be responsible only for its own representations, warranties and covenants hereunder.

 

13.12         Joint
Preparation. The preparation of this Agreement has been a joint effort of the parties and the resulting documents shall not,
solely as a matter of judicial construction, be construed more severely against one of the parties than the other.

 

13.13         Severability.
If any one of the provisions contained in this Agreement, for any reason, shall be held invalid, illegal or unenforceable in any
respect, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement, and this Agreement
shall remain in full force and effect and be construed as if the invalid, illegal or unenforceable provision had never been contained
herein.

 

13.14         No
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

13.15         WAIVER
OF JURY TRIAL. THE BUYERS, THE PLACEMENT AGENT, AND THE COMPANY, AFTER CONSULTING OR HAVING HAD THE OPPORTUNITY TO CONSULT
WITH COUNSEL, EACH KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES, IRREVOCABLY, THE RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY
LEGAL PROCEEDING BASED HEREON, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT
OR ANY OTHER AGREEMENT EXECUTED OR CONTEMPLATED TO BE EXECUTED IN CONJUNCTION WITH THIS AGREEMENT, OR ANY COURSE OF CONDUCT OR
COURSE OF DEALING IN WHICH THE BUYERS AND THE COMPANY ARE ADVERSE PARTIES. THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE BUYERS
TO PURCHASE THE SHARES.

 

[SIGNATURES ON THE FOLLOWING
PAGES]

 

    	 	28	 

     

    

 

Exhibit 10.1

 

IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be executed as of the date and year set forth above.

 

	 	“COMPANY”
	 	 
	 	THEMAVEN, INC.,
	 	a Delaware corporation
	 	 	 
	 	By:	 
	 	 	James Heckman,
	 	 	Chief Executive Officer
	 	 	 
	 	“PLACEMENT AGENT”
	 	 
	 	MDB CAPITAL GROUP, LLC,
	 	a Texas limited liability company
	 	 	 
	 	By:	 

 

Signature Page to Securities Purchase Agreement

 

     

     

    

 

Exhibit 10.1

 

BUYER SIGNATURE PAGE FOR SECURITIES PURCHASE AGREEMENT

 

WITH THEMAVEN, INC.

 

By its execution below,
the undersigned Buyer hereby acknowledges and agrees to the terms set forth in the Securities Purchase Agreement to which this
signature page is attached.

 

	FOR ENTITY INVESTORS:	 	FOR INDIVIDUAL INVESTORS:
	 	 	 	 
	 	 	Signature:	 
	[Name of Entity]	 	Name:	 
	By:	 	 	 	 
	Name:	 	 	Signature:	 
	Title:	 	 	Name:	 
	 	 	 	 	 
	WORK ADDRESS:	 	HOME ADDRESS:
	 	 	 
	 	 	 
	Attention:	 	 	Phone:	 
	Phone:	 	 	SSN:	 
	Fax:	 	 	 	 
	E-mail:	 	 	 	 
	Taxpayer ID#:	 	 	 	 

 

Number of Shares to be Purchased: _________________

 

Amount of Subscription (number of shares X $1.00):
__________________

 

Buyer Signature Page to Securities Purchase
Agreement

 

     

     

    

 

EXHIBIT B

 

ADDITIONAL
RISK FACTORS

 

The shares of the Company’s common stock that have not been
registered under the Securities Act of 1933, as amended (the “Securities Act”), including the Shares issued
pursuant to this Agreement, are subject to resale restrictions imposed by Rule 144 under the Securities Act (“Rule 144”),
including those set forth in Rule 144(i) which apply to a former “shell company.” Pursuant to Rule 144, a “shell
company” is defined as a company that has no or nominal operations and either no or nominal assets, assets consisting solely
of cash and cash equivalents or assets consisting of any amount of cash and cash equivalents and nominal other assets. As such,
the Company was, until November 7, 2016, a “shell company” pursuant to Rule 144 (as further described in the SEC Filings),
and as such, sales of the Company’s securities pursuant to Rule 144 are not able to be made until a period of at least twelve
months has elapsed from the date on which the information that is required by Form 10 to register the Company’s securities
under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) is filed with the Securities and
Exchange Commission (the “Commission”). The Company filed such information with the Commission on November 7,
2016. Therefore, any restricted securities the Company has sold or may sell in the future (including Shares sold pursuant to this
Agreement) or issues to consultants or employees, in consideration for services rendered or for any other purpose, will have no
liquidity until and unless such securities are registered with the Commission and/or until six months after the date of issuance
and we have otherwise complied with the other requirements of Rule 144. As a result, it may be harder for the Company to fund its
operations and pay its employees and consultants with the Company’s securities instead of cash. Furthermore, it will be harder
for the Company to raise funding through the sale of debt or equity securities unless it agrees to register such securities with
the Commission, which could cause the Company to expend additional resources in the future. The Company’s prior status as
a “shell company” could prevent it in the future from raising additional funds, engaging employees and consultants,
and using its securities to pay for any acquisitions, which could cause the value of its securities, if any, to decline in value
or become worthless.

 

Under Rule 144, restricted or unrestricted securities that were
initially issued by a reporting or non-reporting shell company, or a company that was at any time previously a reporting or non-reporting
shell company, can only be resold in reliance on Rule 144 if the following conditions are met:

 

		·	the issuer of the securities that was formerly a reporting or non-reporting
shell company has ceased to be a shell company; 

		·	the issuer of the securities is subject to the reporting requirements
of Section 13 or 15(d) of the Exchange Act; 

		·	the issuer of the securities has filed all reports and material required
to be filed under Section 13 or 15(d) of the Exchange Act, as applicable, during the preceding twelve months (or shorter period
that the Issuer was required to file such reports and materials), other than Form 8-K reports; and 

		·	at least one year has elapsed from the time the issuer filed the current
Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. 

 

At the present time, the Company is not classified as a "shell
company" under Rule 405 of the Securities Act or Rule 12b-2 of the Exchange Act. However, in the event the Company was to
be so designated in the future, Buyers of Shares would be unable to sell such Shares under Rule 144.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]